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ABSTRACT OF DISSERTATION

CHARACTERIZATION AND OPTIMIZATION OF MICROELECTRODE
ARRAYS FOR GLUTAMATE MEASUREMENTS
IN THE RAT HIPPOCAMPUS
An overarching goal of the Gerhardt laboratory is the development of an
implantable neural device that allows for long-term glutamate recordings in the
hippocampus. Proper L-glutamate regulation is essential for hippocampal
function, while glutamate dysregulation is implicated in many neurodegenerative
diseases. Direct evidence for subregional glutamate regulation is lacking in
previous in vivo studies because of limitations in the spatio-temporal resolution of
conventional experimental techniques. We used novel enzyme-coated
microelectrode arrays (MEAs) for rapid measurements (2Hz) of extracellular
glutamate in urethane-anesthetized rats. Potassium-evoked glutamate release
was highest in the cornu ammonis 1 (CA1) subregion and lowest in the cornu
ammonis 3 (CA3). In the dentate gyrus (DG), evoked-glutamate release was
diminished at a higher potassium concentration but demonstrated faster release
kinetics. These studies are the first to show subregion specific regulation of
glutamate release in the hippocampus.
To allow for in vivo glutamate measurements in awake rats, we have
adapted our MEAs for chronic use. Resting glutamate measurements were
obtained up to six days post-implantation but recordings were unreliable at later
time points. To determine the cause(s) for recording failure, a detailed
investigation of MEA surface characteristics was conducted. Scanning electron
microscopy and atomic force microscopy showed that PT sites have unique
surface chemistry, a microwell geometry and nanometer-sized features, all of
which appear to be favorable for high sensitivity recordings. Accordingly, studies
were initiated to improve enzyme coatings using a computer-controlled
microprinting system (Microfab Technologies, Plano, TX). Preliminary testing
showed that microprinting allowed greater control over the coating process and
produced MEAs that met our performance criteria.
Our final studies investigated the effects of chronic MEA implantation.
Immunohistochemical analysis showed that the MEA produced minimal damage

in the hippocampus at all time points from 1 day to 6 months. Additionally, tissue
attachment to the MEA surface was minimal. Taken together with previous
electrophysiology data supporting that MEAs are functional up to six months,
these studies established that our chronic MEAs technology is capable of
maintaining a brain-device interface that is both functional and biocompatible for
extended periods of time.
KEYWORDS: Glutamate, Hippocampus, In Vivo Amperometry, Functional
Biocompatibility, Brain-Microelectrode Interface
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Chapter One: Introduction

For the last thirty years, the hippocampus has been intensively studied by
neuroscientists for its vital role in cognitive learning and memory formation.
Though much is known about the structural and functional properties of neurons
found in this region of the brain, an understanding about how multimodal sensory
information to the hippocampus is encoded into a new memory or learned
behavior is necessary.
The hippocampus is one of the first structures to be affected in
Alzheimer’s disease (Braak and Braak, 1998; Du et al., 2004; van de Pol et al.,
2007) while dysfunction of this brain region has been hypothesized to underlie
disturbances in sensory gating in patients with schizophrenia (Miller et al., 1992).
The hippocampus is also extremely vulnerable to tissue damage from hypoxicischemic injury (Ben-Ari, 1992; Del Bigio and Becker 1994) and recurrent
seizures (During and Spencer, 1993). Knowledge about the molecular
mechanism(s)

responsible

for

the

pathologies

and

cognitive

deficits

accompanying these diseases is needed to aid the development of diagnostic
tools and treatments.

1.1 Neuroanatomy and Physiology of the Hippocampus

The

mammalian

hippocampus

is

composed

of

several

cytoarchitectonically distinct subregions that are connected by a highly organized
three-layer circuit named the trisynaptic pathway (Amaral et al., 1989). Synaptic
communication within this pathway is unidirectional and widely suggested to be
mediated by ionotropic receptors located on the post-synaptic cell membrane,
specifically α – amino – 3 – hydroxyl – 5 – methyl – isoxaole – propionic acid
(AMPA), and N – methyl – D – aspartate (NMDA) receptors (Figure 1.1). The
ligand

activating

these

receptors

is

1

L-glutamate,

the

chief

excitatory

neurotransmitter in the hippocampus and brain. After binding to glutamate, these
receptors

generate

excitatory

post-synaptic

currents

(EPSCs)

that

are

propagated down the length of the neuron via transient changes in the resting
potential of the cell membrane (Andersen et al., 1966).
Viewed in cross-section, the rodent hippocampus appears as a pair of
interlocking U or V shaped structures (Pritchard and Alloway, 2002). The
structure with its crest oriented towards the midline is the dentate gyrus (DG)
while the other structure is called the hippocampal cortex or cornu ammonis (CA)
field. The arms of the DG are called suprapyramidal and infrapyramidal blades
based upon their proximity to the cortical surface of the brain. The hippocampal
cortex also consists of supra and infrapyramidal blades; the former is commonly
known as the CA1 field while the latter is the CA3. Each structure is composed of
three cell layers. Starting at the pial surface and going outwards, these are the
molecular, granule and polymorphic cell layers for the DG and stratum radiatum,
stratum pyramidale (lucidum for the CA3) and stratum oriens for the CA fields.
The trisynaptic pathway is formed by neurons with cell bodies located in
the principal cell layer of each subregion, i.e., granule and pyramidal cell layers
because these are the only neurons giving rise to axons that innervate the
adjoining hippocampal field. Figure 1.2 is a simplified illustration of the trisynaptic
pathway and shows the relative anatomical location of these principal neurons.
Axon terminals from layer II (and minor projections from layers V and VI) of the
entorhinal cortex (EC) connect with dendrites of granule cells in the molecular
layer of the DG, forming the first synapse of the trisynaptic circuit (Steward and
Scoville, 1976). These afferent fibers also represent the major input to the
hippocampus, known as the perforant pathway. Axons of granule cells, known as
mossy fibers, form the second synapse by connecting to dendrites and soma of
pyramidal cells in the CA3 through the mossy fiber pathway. Dendrites in the
CA1 region receive their primary excitatory input from Schaffer collaterals, which
are axons of CA3 pyramid cells. This connection forms the third synapse. Finally,
the CA1 provides the extrinsic projection out of the hippocampus to the
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subiculum, ultimately closing the trisynaptic loop through direct and indirect
synaptic connections with layer III of the EC.
Outside of the serial connections of the trisynaptic pathway, the principal
neurons

in

each

hippocampal

field

also

receive

‘parallel’

excitatory

(glutamatergic) inputs from intrinsic and extrinsic sources (Figure 1.3). For
example, granule cells form reciprocal contacts with mossy cells located in the
polymorphic layer of the ipsilateral and contralateral DG. These connections are
believed to serve as a significant source of excitation for granule cells. Similarly,
CA3 pyramidal neurons are heavily innervated by their own collaterals
(associational inputs) while also forming reciprocal connections with pyramidal
cells in the contralateral CA3 (commissural connections) (Ishizuka et al., 1990; Li
et al., 1994). They also receive projections from layer II of the EC. In contrast to
the DG and CA3, very few associational connections have been observed in the
CA1 though it receives excitatory inputs from a separate set of EC terminals
(layer III) (Witter, 1993).
Pyramidal cell response in the hippocampus is also modulated by other
neurotransmitters and neuropeptides. Each subregion is populated by a wide
variety of interneurons that provide monosynaptic and disynaptic inhibitory
control of excitatory outputs. A study by Walker et al (2002) showed that at least
some mossy fibers terminating in the CA3 are immunoreactive for GABA and
dynorphin. Other than local interneurons, the DG receives cholinergic and GABAergic inputs from septal nuclei in the basal forebrain (Andersen et al., 2007).
Similar projections to CA fields are both bilateral (to both brain hemispheres) and
reciprocal. Of these, the cholinergic projections are powerful modulators of
neuronal excitation. Both muscarinic and nicotinic choline receptor subtypes are
known to influence glutamate release from pyramidal neurons (Chessell and
Humphrey, 1995; Dijk et al., 1995). Finally, the hippocampus receives discrete
noradrenergic, serotonergic and dopaminergic inputs from the basal forebrain
and regions of the brainstem. While the functional implications of this complex
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circuitry are not completely understood, it appears that hippocampal subregions
are not entirely dependent on the trisynaptic circuit for their function.
Almost all the neuronal projections mentioned up to this point follow a
convergent-divergent type of connectivity that is unique to the hippocampus. For
example, the axon of a single granule cell forms contacts with many CA3
pyramidal cells (divergence). Though each pyramidal cell only forms a few
contacts with this axon, it receives similar projections from many granule cells
(convergence). The nature of this connectivity has led researchers to
hypothesize that each substructure functions semi-independently, while also
operating in concert with other hippocampal fields (Kesner and Hopkins, 2006).
Support for this theory comes from electrophysiological recordings where
pharmacological inactivation of granule cells appears to have no effect on CA1
neuronal activity (Andersen et al., 2007). More recently, a study by Greene et al
(2009) provided evidence for dissimilar gene expression profiles between
principal neuron layers, shown by experiments of laser-capture microdissection
and microarray hybridization. Their study showed that pyramidal neurons could
be differentiated both from granule cells and from each other. Based on the
number and type of mRNA transcripts expressed in each region, the authors
proposed that functional differences between regions are more likely to be due to
wide-ranging expression differences of modest magnitude than extreme
differences in a few genes. Greene and colleagues also described specific
differences in transcripts related to energy metabolism or cell survival that may
have significant implications for the functional and physiological properties of
each region. Collectively, these studies emphasize the importance of conducting
discrete investigations in each subregion.
The cellular architecture and connections described in the preceding
paragraphs correspond to the rat hippocampus, but can be used to model brain
function in higher mammals for experimental purposes because of highly
conserved phylogeny between species (Squire et al., 1992). Differences of note
are the relatively thicker CA1 in humans and a greater number of EC
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subdivisions in humans. Rats also have substantial commissural projections that
constitute nearly one sixth of the excitatory input to the rodent dentate gyrus
(Raisman 1965, Gottlieb and Cowan, 1973). Hippocampal commissural
connections are almost entirely absent in primates (Amaral et al. 1984). These
are important considerations when extrapolating the results of animal studies to
the clinical setting.

1.2 Glutamate Regulation and Hippocampal Function

As described earlier, glutamate is the predominant neurotransmitter for
receptor-mediated excitatory transmission in the hippocampus. Glutamate
synthesized in presynaptic nerve terminals is transported into vesicles by
vesicular glutamate transporters (VGLUTs) and exocytosed into the extracellular
environment following calcium-dependent release of glutamate from synaptic
vesicles (Bellocchio et al., 2000). Astrocytes also release glutamate (Angulo et
al., 2004; Volterra and Steinhauser, 2004), and are suggested to be an important
modulator of hippocampal glutamate transmission, though their precise role is
not completely understood (Araque et al., 1999). Glutamate receptors, both
ionotropic and metabotropic subtypes, are widely distributed on neuronal and
glial cell membranes, therefore high level control over neurotransmitter
concentration is necessary to maintain targeted activation of post-synaptic
glutamate receptors (Meldrum, 2001). Immediately following release, glutamate
is rapidly removed from the synapse by a family of high-affinity, sodiumdependent transporter systems. Of the known subtypes, the most abundant
glutamate transporter in the rodent hippocampus is GLT-1, followed by EAAC1
and GLAST (Rothstein et al., 1994; Danbolt, 2001). GLT-1 and GLAST are
exclusively expressed in astrocytes while EAAC1 is found on pyramidal cell
bodies and their post-synaptic dendrites. The corresponding human transporters
are referred to as EAAT2, EAAT1 and EAAT3, respectively. In both species, over
90% of extracellular glutamate is actively transported out of the extracellular
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matrix by GLT-1 and GLAST, providing further evidence for the importance of
glial cells in maintaining normal glutamate transmission in the hippocampus and
other brain regions (Haugeto et al., 1996; Danbolt, 2001).
Glutamate is believed to contribute to hippocampal-dependent learning
and memory through long-term potentiation (LTP), a form of increased synaptic
strength that occurs following brief, high frequency electrical stimulation (100 Hz)
of glutamatergic fibers (Kullmann et al., 1996). Indirect evidence for glutamate
involvement comes from combined pharmacological and behavioral studies in
rodents where NMDA receptor antagonists impaired behavioral learning while
agonists for NMDA and AMPA receptors produced the opposite effect (Francis et
al., 1993). Human studies of LTP are lacking for obvious reasons; however,
lesioning of portions of the human hippocampus as a result of disease or injury
resulted in cognitive deficits and variable levels of amnesia, similar to
experimental findings (Andersen et al., 2007). It is important to mention here that
much of our knowledge about LTP comes from electrophysiological studies of ex
vivo hippocampal tissue (particularly in CA1) whereas our understanding of
hippocampal-dependent learning processes is based on neuropsychological
testing. Therefore, a major goal for in vivo electrophysiolgical studies has been to
determine if the experimental paradigm of LTP truly represents memory encoding
(Baudry and Lynch, 2001; Bliss and Collingridge, 1993). Until now, the
overwhelming majority of evidence shows indirect associations. One explanation
for this could be a lack of direct information about alterations in glutamate
regulation during LTP processes.
Interestingly, LTP in the CA3 does not require synchronized pre- and
postsynaptic activity at mossy fiber-CA3 pyramidal cell synapses (Synapse 2)
(Daoudal et al., 2002) and receptor antagonists against AMPA and NMDA do not
block this form of LTP (Bortolotto et al., 2005; Kwon and Castillo, 2008). The
consensus is that mossy fiber LTP is mediated by a different set of glutamate
receptors, specifically kainate-sensitive glutamate receptors (KARs) and
metabotropic glutamate receptors (mGluRs) (Kwon and Castillo, 2008).
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Glutamate involvement has also been suggested in the induction of longterm depression (LTD), a process where decreased synaptic strength is
observed following prolonged low-frequency electrical stimulation (Mockett et al.,
2002; Sajikumar and Frey, 2003; Sajikumar and Frey, 2004). Unlike LTP, LTD is
not NMDA-dependent but is believed to be an important homeostatic mechanism
that determines the stability of the hippocampal neuronal network. However, LTD
is sensitive to AMPA or metabotropic glutamate (mGlu) receptor antagonists
(Kemp and Bashir, 1999).
Apart from the different kinds of long-term plasticity changes, hippocampal
synapses demonstrate numerous forms of short-term ‘memory’ that last for much
shorter periods (minutes to hours) but may play an equally important role in realtime information relay between terminals (Thomson, 2000; Zucker and Regehr,
2002). Common substrates for investigations on this type of memory are the
synapses formed by Schaffer collaterals and CA1 pyramidal neurons and those
between principal neuron projections onto hippocampal interneurons. These
synapses can show either depression or facilitation with repeated stimulation,
depending on the identity of the postsynaptic terminal. Glutamate involvement in
these transient processes is implied but the precise mechanism remains
unknown.
Modulation of glutamatergic effects during active learning can be from
multiple sources. One form of intrinsic control is by feedback inhibition or
disinhibition by presynaptic glutamate receptors (iGluR and mGluR subtypes with
variable distribution in different subregions) following synaptic glutamate release.
Mossy fibers demonstrate an additional level of pre-synaptic control because
they co-release GABA and dynorphin along with glutamate which can activate
GABA autoreceptors (Andersen et al., 2007). Glia also contribute to intrinsic
control by adjusting transporter efficacy. Other forms of feedback/feed-forward
inputs arise from associational/commissural contacts (DG granule cells and CA3
pyramidal cells) or reciprocal connections (DG-mossy cells). Finally, cholinergic
and GABA-ergic effects of extrinsic neuronal sources on hippocampal plasticity
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must be considered. Together, these studies support the view that regulation of
glutamate is different in subregions of the hippocampus and thereofore, should
be investigated separately.

1.3 Glutamate Neurotransmission in the Aging Hippocampus

Aging is not a medical condition; however aging is associated with
structural and functional changes that can increase an individual’s risk factor for
certain diseases. The aging hippocampus, in particular, is an early target of
physiological changes that have been correlated with mild cognitive impairment
and diminished capacity for memory recall (de Toledo-Morrell et al., 1995). The
aged

hippocampus

also

demonstrates

increased

susceptibility

to

neurodegenerative diseases believed to have an excitotoxic component, such as
temporal lobe seizures (Michaelis et al, 2001) and Alzheimer’s disease
(Greenamyre and Green, 1989). Because elderly individuals are the fastest
growing sub-population in the United States, age-related alterations in
hippocampal glutamate neurotransmission need to be identified and studied
systematically.
Repeated experiments using high intensity stimulation protocols have
demonstrated that LTP induction remains intact during aging in CA1 and DG
tissues (Landfield and Lynch, 1977; Diana et al., 1994). However, time for LTP
decay (Barnes and McNaughton, 1980) and LTD induction (Norris et al., 1996)
was decreased in aged rats. These changes were correlated with behavioral
testing suggesting that aged rats not only took longer than their young
counterparts to encode new memories, but they also retained fewer new
memories. Since LTP and LTD are NMDA-dependent processes, alterations in
post-synaptic glutamate regulation can be expected in these regions.
As reviewed by Barnes and Rozensweig (2003), a majority of the basic
cellular characteristics of DG granule cells, and CA pyramidal cells do not
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change with age, including resting membrane potential (Potier et al., 1992, 1993)
and total neuron counts, though reduced hippocampal volume was observed in
previous studies. These results suggest that age-related cognitive deficits are
produced by other factors such as dendritic shrinkage, reduced synapse
numbers, altered release kinetics or changes in the function of receptors and
transporters. Again, these changes are not widespread but only affect some
aged animals, indicating a mechanism for biological compensation. Indeed, a
reduction in perforant path-granule cell synapse numbers and NMDA-mediated
LTP was accompanied by increases in the strength of remaining synapses
through AMPA receptors (Rao et al., 1994; Barnes et al., 1992). In contrast, the
Schaffer collateral-CA1 circuit showed a decrease in synaptic contacts without
compensation from NMDA or AMPA receptors. Rather, a decrease in
postsynaptic response was correlated with impaired behavioral performance in
aged rats. Age-related declines in the number of AMPA receptor binding sites,
but not NMDA receptor binding sites were noted in the DG. Alterations in number
of AMPA receptors with age have not been observed in the CA fields though a
decrease in synaptic contacts was also noted in the CA3 (De Groot and Bierman,
1987).
Two important changes occur in astrocytes with aging. First astrocyte
hypertrophy (or reactive gliosis) is observed in some studies, indicated by
elevated levels of astrocyte-localized glial fibrillary acidic protein (GFAP)
throughout the aging brain including the hippocampus (Linnemann et al., 1994).
Typically considered an injury response, the presence of gliosis may be a sign of
increased oxidative stress or inflammation in the aged hippocampus (Segovia,
2001). Astrocyte numbers are also diminished during aging along with a
decrease in transporter number (Segovia et al., 2001) though the glutamate
uptake and/or release capacity of reactive astrocytes is not well understood.
Compensatory increases in transporter affinity or presynaptic release are
possible (Saransaari and Oja, 1995) but until now a technique to investigate
glutamate kinetics has been largely lacking. Prior scientific research has
employed microdialysis to study changes in total hippocampal concentration of
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extracellular glutamate in the aging hippocampus. Even here, only two reports
are available (Massieu and Tapia, 1997; Zhang et al., 2001), and their results are
contradictory. The former reported an increase in tonic glutamate concentration
with aging while the latter reported no change. Clearly, an improved methodology
for studies of glutamate in discrete hippocampal subregions during aging is
needed to correlate focal changes in excitatory transmission with hippocampal
function.

1.4 Glutamate Dysregulation in Hippocampal Disease
1.4.1 Alzheimer’s disease
The early involvement of hippocampal subregions in the pathophysiology
of Alzheimer’s disease (AD) is well-established. Specifically, a selective decline
in numbers of pyramidal neurons and associated synapses is observed at all
stages of the disease (Braak and Braak et al., 1998). Tissue samples examined
in their study conained amyloid plaques and neurofibrillary tangles, which are
now believed to be the hallmarks of AD pathology (Maragakis and Rothstein,
2001). Further evidence for loss of hippocampal function in AD is provided by
memory deficits and impaired performance during cognitive tests (Vandenberghe
and Tournoy, 2004), both of which are key diagnostic indicators in elderly
patients.
Disruption of hippocampal glutamate transmission occurs early in the
disease process. Axons from layer II and III of the entorhinal cortex (EC) carrying
the excitatory inputs to the hippocampus via the perforant pathway are the first to
develop AD pathology and undergo neurodegeneration. This causes the
hippocampus to become disconnected from the EC, leading to a major reduction
in glutamatergic input to all principal neurons in hippocampal subregions.
Interestingly, neurodegeneration does not affect all regions equally. The CA1
region is primarily affected, followed by the CA3 and DG in advanced phases of
AD. This is supported by histopathological observations of post-mortem brain
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tissue of early AD cases (Morrison and Hof, 1997). Neurons with positive
immunoreactivity for glutamate are reduced in number and co-stain for
neurofibrillary tangles in the CA1 field (Kowall and Beal, 1991). Again, glutamate
synthesis by glutaminase appears to be unaffected in AD (Procter et al., 1988)
but total numbers of glutaminase-containing neurons showed tangle formation
and reduced numbers. These data suggest a role for pre-synaptic dysregulation
of glutamate.
Studies using antibodies directed against the individual glutamate
transporters reveal conflicting data. Reduced levels of GLT protein (but not
mRNA) with normal levels of both GLAST and EAAC were reported by Li et al
(1997) but not confirmed by Beckstrom et al (1999) though this may be due to
differences in the handling of post-mortem tissue methodologies. A separate
study by Duerson et al (2008) revealed changes in the detergent-solubility of
neuronal glutamate transporter EAAC1. Selective loss of NMDA receptor is
greater in AD than in aging (Greenamyre and Maragos, 1993). EAAC1 is not a
major contributor for uptake of extracellular glutamate. However, it is implicated
in the regulation of GABA transmission, which can have an indirect effect on
glutamate through feedback inhibition. KARs are relatively spared in AD
neurodegeneration but tissue levels of AMPA receptors are reduced (relative to
disease-free aging) in several regions of the brain including the hippocampus
(Yasuda et al., 1995; Armstrong and Ikonomovic, 1996). An emerging theory
suggests that glutamate dysregulation precedes the pathology of AD because
alterations in glutamate receptor content occur prior to the formation of
neurofibrillary tangles (Armstrong et al., 2003).
The severe decrease in NMDA receptors in AD pathology has led to an
interesting hypothesis on the mechanism of glutamate excitoxicity in the
pathogenesis of AD (Greenamyre and Young, 1989). Excitotoxic damage from
overexposure to glutamate generally occurs when the uncontrolled release of
glutamate surpasses the capacity of astrocyte uptake mechanisms. The resulting
overactivation of NMDA receptors triggers a cascade of signaling events that can
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cause downregulation of NMDA expression on the cell membrane, or in severe
cases, cell death (Danbolt, 2001). Greenamyre and Young 1989) proposed that
failure to remove non-pathological glutamate by the transporter system can also
lead to glutamate accumulation and the aforementioned excitotoxicity pathway.
Uptake failure can occur if the energy-dependent transporters do not receive
sufficient adenosine tri-phosphate (ATP) or if the transporter protein is damaged
by oxidative processes. Evidence for impaired energy metabolism, increased
glucocorticoid accumulation (an oxidative stress indicator) and protein damage
have been seen in several studies (Francis et al., 1993; Beal, 1998; Smith et al.,
1996; Keller et al., 1992). Experimentally as well, application of excessive
glutamate in neuronal culture induces simplification of the pyramidal cell’s
dendritic tree (Mattson, 1988; Mattson et al., 1988), a feature of AD pathology
(Mann et al., 1986; Mehraein et al., 1975). Biochemical data has shown
decreased extracellular glutamate levels in AD (Hyman et al., 1987; Lowe et al.,
1990). Accordingly, a more agreed-upon theory is glutamate hypoactivity in the
AD-affected hippocampus caused by the selective death of pyramidal neurons
(Keller et al., 1997), resulting in loss of normal trisynaptic pathway connections.
Pyramidal neurons are also the site of hyperphosphorylation for protein Tau
(responsible for tangle formation) and for the metabolism of amyloid precursor
protein to Aβ (Francis et al., 2003). The main point of this discussion is the lack
of availability of a technique that directly measures the time course of changes in
glutamate transmission in Alzheimer’s disease along with a lack of proper animal
models for in vivo studies.
1.4.2 Schizophrenia
The pathophysiology of schizophrenia involves the prefrontal cortex (PFC)
and mesial temporal lobe structures, including the hippocampus (for review, see
Freedman and Goldowitz, 2009). Decreased hippocampal volume due to a
reduction in neuronal size, not number has been reported in early stages of the
disease (Nelson et al., 1998, Arnold et al., 2005). Abnormalities such as atypical
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orientation of CA pyramidal cells and absence of gliosis have led researchers to
hypothesize that schizophrenia is a developmental disorder.
Theories about glutamate involvement in schizophrenia are not new. In
situ hybridization of human hippocampal tissue obtained post-mortem showed
that metabotropic receptor mGluR5 and glial transporter EAAT2 were similar for
patients with schizophrenia and control tissue samples (Ohnuma et al., 2000). In
contrast, diminished expression of VGLUT1 mRNA was noted in presynaptic
terminals of hippocampal cells along with decreased activity of post-synaptic
NMDA receptors (Eastwood and Harrison, 2004). A loss in AMPA receptors has
also been observed, usually in the left hippocampus (Kerwin et al., 1988). To our
knowledge, the functional implications of these changes have not been directly
investigated. One study used magnetic resonance spectroscopy and found that
total glutamate concentration was significantly higher in both prefrontal cortex
and hippocampus of schizophrenic patients compared to other brain regions but
behavioral correlates were only observed for the PFC (van Elst, 2005). Finally, a
striking example of hippocampal involvement is observed in temporal lobe
epilepsy where some patients demonstrate a psychosis that is indistinguishable
from schizophrenia (Andersen et al., 2007)
Glutamate is also involved in many aspects of neuronal synaptic strength
and function during development and throughout life. Synapse formation in early
brain development, synapse maintenance, and synaptic plasticity are all
influenced by the glutamate system. If schizophrenia is indeed determined to be
the result of impaired neural development, dysregulation of glutamate can be
conceived to play a major role.

1.5 Rapid Glutamate Measurements using Microelectrode Arrays coupled
with In Vivo Amperometry
As discussed earlier, much of our present understanding about the
neurotransmitter

role

of

glutamate
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has

come

either

from

ex

vivo

electrophysiological investigations conducted in hippocampal tissue slices,
isolated nerve terminals and cell cultures (Nicholls et al., 1993; Hjelmstad et al.,
1997; Takeda et al., 2007) or from in vivo recordings using microdialysis probes
(Bagley and Moghaddam, 1997). Data obtained from electrophysiology studies is
often inconsistent, partly due to variations in the experimental methodology
followed by different research groups, but more likely due to the inherent
limitations of studying a brain region without its complete set of intrinsic and
extrinsic connections. In addition, electrophysiology does not allow for direct
measurement of glutamate concentration.

The microdialysis technique has

addressed some of these limitations; however, microdialysis investigations of the
rodent hippocampus are limited to whole tissue studies because of restrictions in
the spatial resolution (microdialysis probes are 1-4 mm in length while the rat
hippocampus is only 5-6 mm wide in cross-section). Also, dynamic properties of
glutamate neurotransmission cannot be investigated through microdialysis
recordings because the slow sampling rates of this technique (seconds to
minutes) cannot capture rapid glutamate release and uptake (milliseconds to
seconds; Kinney et al., 1997) events. A detailed understanding about glutamate
neurotransmission kinetics is needed because subtle changes in synaptic
connectivity may be masked by biological compensation, possibly leading to
unchanged levels of tonic glutamate.
The above mentioned limitations have warranted the development of new
methods that can offer sensitive, reliable measurements of glutamate and other
neurochemicals in the central nervous system (CNS). In vivo amperometry is one
such recording technique that utilizes microelectrodes which can be targeted to
different brain structures. The recording surface(s) or working sites of the MEA is
usually composed of Platinum (Pt) or other inert metals. When a constant and
sufficient potential is applied to the working sites against a reference electrode,
the MEA is capable of oxidizing or reducing electroactive molecules. The current
generated by the resulting Faradaic reaction can be monitored continuously and
rapidly (≤1 ms) (for review, see Gerhardt and Burmeister, 2000). The current is
also linear with respect to concentration of the electroactive molecule(s) in the
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tissue adjacent to the working sites, allowing for in vitro calibration for in vivo
investigation. Finally, because the working electrode is continuously maintained
at a fixed potential, the non-Faradaic background current detected by the MEA is
extremely low, allowing for highly sensitive measurements (pA - nA).
Using these principles, we have developed ceramic-based microelectrode
arrays (MEAs) that are capable of measuring rapid tonic and phasic
neurotransmitter changes in the central nervous system (CNS) (Burmeister et al.,
2001; Pomerleau et al., 2003). Our MEAs are composed of a 2 x 2 array of
micron-sized Platinum (Pt) recording sites arranged in dorsal-ventral pairs on a
smooth ceramic substrate (Coors Ceramic Co., Golden, CO) (Figure 1.4 A). A
low noise, computer controlled, multi-input potentiostat (Fast16mkII recording
instrumentation, Quanteon LLC, Nicholasville, KY) completes the external circuit
and allows simultaneously recordings from all the Pt sites.

To extend the

recording capability of the MEAs to non-electroactive neurotransmitters such as
glutamate and choline, our laboratory has pioneered the use of oxidase enzyme
coatings (Burmeister et al., 2001, 2006, 2007). These enzymes oxidize the
molecules of interest and convert them to hydrogen peroxide ‘reporter’
molecules. When a constant potential of +0.7 V is applied to the MEA vs. an
Ag/AgCl reference, H2O2 donates two electrons to the Pt sites. The two step
reaction for glutamate catalysis is given below:
L-glutamate + H2O + GluOx/FAD

α-ketoglutarate + NH3 + GluOx/FADH2

GluOx/FADH2 + O2

GluOx/FAD + H2O2

Our standard MEA design (S2 MEA) (Figure 1.4 A) has a temporal
resolution of 2 Hz, allowing subsecond detection of glutamate neurotransmission.
Since in vivo glutamate release appears as a characteristic fast current spike
lasting a few seconds, a change in glutamate signaling can be correlated to
specific alterations in glutamate release or uptake. We have used this capability
to study glutamate in discrete brain structures like the striatum and PFC of rats
(Nickell et al., 2005; Day et al., 2006), the striatum and nucleus accumbens of
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mice (Thomas et al., 2008) and in the motor cortex of anesthetized rhesus
monkeys (Quintero et al., 2008), under urethane anesthesia. For the studies
presented in this dissertation, we developed a novel MEA design (W4 MEA),
comprised of smaller Pt sites (20 X 150 μm) (Figure 1.4 B). The total recording
area of the W4 MEA is approximately 40% smaller than the S2 MEA, making it
more appropriate for discretely targeting the DG, CA3 and CA1 subregions of the
rat hippocampus.

1.6 Thesis Outline
Since information relay in the hippocampal trisynaptic pathway takes
places through synaptic connections using glutamate as their chief excitatory
neurotransmitter,

we

believe

that

differential

regulation

of

glutamate

neurotransmission within the DG, CA3 and CA1 subregions contributes to
differences in subregional hippocampal function. To investigate this hypothesis,
the studies described in this dissertation used a novel MEA design (W4-MEA) in
combination with amperometric measurements to gain novel insight into
hippocampal regulation of glutamate neurotransmission. In addition, the present
studies provided compelling evidence to support the superior biocompatibility of
W4- MEAs for long term neurochemical and electrophysiological measurements.
Chapter Two provides a detailed description of study designs, animal subjects,
materials, instrumentation, methodology, data selection criteria and statistical
analyses used in all experiments.
Chapter Three investigates the release and clearance characteristics of
glutamate neurotransmission from excitatory nerve terminals in discrete DG, CA3
and CA1 subregions of the anesthetized rat hippocampus. In vivo measurements
showed that subregional levels of resting glutamate were not significantly
different in anesthetized F344 rats. However, the trisynaptic pathway does exhibit
subregional differences in evoked glutamate release following local application of
70 or 120 mM KCl. Of the three subregions, capacity for glutamate release was
highest in terminals localized to the CA1 field and least from the CA3 subregion.
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These data suggest that less glutamate was found in the extracellular space
around the MEA in the CA3 region. The most fascinating findings in this study
were from KCl studies in the DG subregion. KCl-evoked glutamate release
capacity in DG terminals was significantly diminished following high K+
stimulation but demonstrated faster release kinetics, providing evidence for
modulation of presynaptic glutamate release from local nerve terminals.
Clearance of exogenous glutamate was not significantly different in the DG, CA3
or CA1 subregions, suggesting similar capabilities for glutamate clearance in the
trisynaptic circuit. Finally, depth profile investigations of hippocampal layers in the
CA1 and DG demonstrated cell layer-specific differences in evoked glutamate
release capacity, as seen with local application of 70 mM KCl. Collectively, these
findings validate the capability of the W4 MEA to target discrete cell layers of the
rat hippocampus and provide direct evidence for subregion specific regulation of
glutamate neurotransmission in the anesthetized rat hippocampus.
Chapter Three also evaluated the recording capability of chronic W4MEAs in the CA1 subregion of unanesthetized F344 rats. These studies showed
that the MEA was able to measure glutamate up on days 4, 5 and 6 post-surgery.
Average levels of resting glutamate were not significantly different, indicating that
W4-MEAs are capable of measuring hippocampal glutamate over multiple days
and can be combined with behavioral experiments for future investigations in
unanesthetized rats.
In Chapter Four, we characterized the ceramic and Pt surfaces of our
MEAs. In vitro calibration showed that S2 and W4-MEAs were comparable with
respect to recording sensitivity, though limit of detection was significantly higher
for W4-MEAs. Scanning electron microscopy and atomic force microscopy of Pt
sites showed that the photolithographic manufacturing process produces
recording sites with microwell geometry and nanometer-sized surface features. In
addition, x-ray dispersion spectroscopy showed that the Pt sites likely exist in
their native metallic state and are not bound to oxygen atoms. These studies are
the first to describe the surface properties of an implantable ceramic-based
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neural device and are expected to aid our ongoing efforts to improve and extend
the recording performance of our MEA technology.
The studies in Chapter Five investigated the coating methodology and
salient characteristics of two computer-controlled microprinting devices, namely
the Nanoject microplotter (courtesy: Thom Coates) and the Jetlab® microprinter
(Microfab Technologies, Plano, TX). Precise coatings of choline oxidase were
applied on discrete Pt sites using a pressure-controlled fluid release system. We
empirically determined that at least 8 serial applications of enzyme solution and 4
applications of gluteraldehyde were needed to produce a stable cross-linked
enzyme layer. The performance of these MEAs was not significantly different
from manually coated MEAs; however, these studies required extensive human
involvement and had a longer operating time. Next, we characterized the
operating parameters for the Jetlab® microprinting station. Specifically, we
determined a range of operating parameters (calibration factors, drop size and
drying behavior) that allowed for application of choline or xanthine oxidase
solutions onto Pt sites of MEAs from a piezoelectric jetting device. For the very
first time, we were able to apply uniform coatings of choline and xanthine oxidase
onto separate Pt sites. Initial testing of MEA performance conducted at Microfab
laboratories showed that Jetlab coated MEAs are comparable to their manually
coated counterparts. High precision coatings were accompanied by lesser down
time and high turnover of coated MEAs. At the present time, we were not able to
replicate the necessary MEA performance at the University of Kentucky. We
believe that the difference in results is due to a larger droplet size. Additional
experiments are ongoing, however, our initial studies support that this coating
methodology offers a greater range of coating capabilities, shorter coating time
and greater control over the coating solution.
Finally, Chapter Six focused on the brain tissue reaction to W4-MEAs
following implantation in the rat hippocampus. We demonstrated that MEA
implants were well-tolerated up to six months, with few post-operative
complications. At all time points, the MEA was surrounded by a highly active
cellular sheath that was immunoreactive for GFAP (astrocytes) and Iba1
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(microglia). Iba1 levels were significantly elevated from 1 to 8 weeks post-surgery
but became diminished at later time points. GFAP immunoreactivity was also
significantly higher by 1 week and remained high 6 months after surgery.
However, the cellular sheath was less than 100 µm wide at early time points and
was significantly contracted by 4 months ≤( 50 µm) suggesting that only a small
amount of tissue in the immediate vicinity was affected. We also studied GFAP
content on the surface of MEA implants. Two explanted probes (out of 30)
showed limited GFAP immunoreactivity confirming a lack of astrocytic content on
the ceramic surface. In addition, scanning electron microscopy found very little
tissue adhered to the ceramic surface suggesting that cell attachment to the
implant was much weaker than intercellular attachment within the sheath.
Collectively, these results indicated that minimal tissue damage resulted from
insertion of the MEA and its prolonged presence in the hippocampus.
Copyright © Pooja Mahendra Talauliker 2010
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Postsynaptic Membrane

Figure 1.1: Glutamate synapse. Glutamate synthesized in presynaptic nerve
terminals is transported into vesicles by vesicular glutamate transporters and
exocytosed into the extracellular environment following calcium-dependent
depolarization of the cell membrane Glutamate receptors NMDAR, AMPAR, KAR
and mGluR are widely distributed on neuronal and glial cell membranes.
Immediately following release, excess glutamate is removed from the
extracellular space by glutamate transporters (GluTs). Glutamate that is not
recovered can diffuse to presynaptic mGluRs and auto-regulate glutamate
release.

Once internalized by glia, glutamate is converted to glutamine,

transported to neurons and converted to glutamate for vesicle loading.
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Figure 1.2: Hippocampal trisynaptic pathway. The trisynaptic pathway
represents the unidirectional flow of excitatory glutamatergic neurotransmission
throughout the hippocampal formation.

The first synapse is at the terminal end

of perforant path projections to granule cells of the dentate gyrus (DG) from the
entorhinal cortex (EC), the second synapse is formed between mossy fiber
projections and pyramidal cells in cornu ammonis 3 (CA3) field and the third
synapse consists of CA3 Schaffer collateral projections and pyramidal cells in
cornu ammonis 1 (CA1). (Figure adapted from Andersen et al., 2007)
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Figure 1.3: Serial and parallel excitatory connections in the hippocampus.
Outside of the ‘serial’ connections of the trisynaptic pathway (thick black arrows),
the principal neurons in each hippocampal field also receive ‘parallel’ excitatory
inputs from intrinsic (double-headed arrows inside boxes) and extrinsic sources
(thin black arrows). (Figure adapted from Andersen et al., 2007)
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Figure 1.4: S2 and W4 MEA designs. Panel A shows the tip of our standard
MEA design, the S2 MEA. Panel B shows the W4 MEA design which was
specifically developed for in vivo hippocampal studies. Both designs consist of 2
pairs of Pt sites arranged in dorsal-ventral pairs though the W4-MEA has smaller
site length.
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Chapter Two: Materials and Methods

2.1 The Fischer 344 Rat as a Model for Studies of Human Hippocampal
Function
Genetically-defined rodents have long been favored for studies of central
nervous system development and function. Classical inbred rodent strains such
as Fischer 344 (F344) and Brown Norway (BN) rats and C57BL/6 and BALB/C
mice have been particularly useful for in vivo investigations in small sample sizes
with low variance (Lipp et al, 2005; Witgen et al 2006). Of these, the F344 rat has
traditionally been utilized in aging studies. As a result, much is known about the
neuroanatomy, physiology and brain tissue morphology of this strain. The F344
rat central nervous system (CNS) has served as an excellent model for
investigations of hippocampal-dependent learning (Fordyce and Farrar, 1991;
Bickford et al., 1997) and dysfunction, particularly for Alzheimer’s disease (Flood
and Coleman, 1983; Pyapali and Turner, 1996) and temporal lobe epilepsy
(Hattiangady, Rao and Shetty, 2004; Rao et al., 2007), where disease-associated
neurodegeneration is known to have focal effects on the hippocampus. Based on
this information as well as the relatively lower cost, ease of availability and low
maintenance needs of this strain, we felt justified in choosing the F344 rat model
for our investigations. It is important to note that some studies report poor
behavioral performance in this strain during memory testing and spatial
navigation tasks when compared to same-aged outbred rats (Lindner and
Gribkoff, 1991). However, Rapp and Gallagher (1996) reason that since total
neuron number is unchanged between the strains compared, this difference is
likely due to reduced visual acuity, a common recessive trait in albino rats. This
explanation is supported by behavioral data from their study where F344 rats
showed improved performance during Morris water maze testing after extended
periods of training.
The work presented in this dissertation describes novel studies of
glutamate neurotransmission in substructures of the normal hippocampus, along
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with a detailed evaluation of the hippocampal tissue response to long term device
implantation (6 months). Therefore, factors such as animal gender, age, lifespan
and state of health were carefully considered. While both male and female F344
rats are used by researchers, we chose male rats to circumvent hormone-related
variability in hippocampal glutamate signaling (Veng, Granholm and Rose, 2003).
Also, to eliminate age-associated changes in hippocampal function (Kiang-ulrich
and Horvath, 1984; Giovanni et al., 1994), we studied rats in the age group 3-5
months. F344 rats reach developmental maturity at 7 weeks (Source: National
Institute of Aging); therefore the rats used in these studies are considered young
adults. In addition, age-matched F344 rats demonstrate comparable body
weights and brain size (Masoro et al., 1993). Finally, exposure to novel stimuli
has been shown to alter hippocampal circuitry (Zhu et al., 1997; Rutishauser,
Adam N. Mamelak and Erin M. Schuman, 2006). Inadvertent data bias of this
kind was minimized by omitting environmental enrichment in these studies
(Gagne et al., 1998; Andin et al., 2007).

2.2 Ethical Standards for the Care and Use of Animals
Male F344 rats (n = 72) were obtained at 12 weeks of age from Harlan
Sprague-Dawley Inc. (Indianapolis, IN). All animal procedures were approved by
the Institutional Animal Care and Use Committee at the University of Kentucky.
Rats were maintained 1-2 per cage with unrestricted access to food and water
per guidelines provided by the Association for Assessment and Accreditation of
Laboratory Animal Care International (AAALACI). A 12-hour light / 12-hour dark
cycle of illumination was maintained for all studies.

2.3 Surgery Procedures
2.3.1 Studies in Anesthetized Animals
For a detailed description of anesthesia procedures, please refer to Day et
al (2006) and Hascup et al (2006). In brief, 25% w/v Urethane solution (1.25
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mg/kg administered intraperitoneally) was used to induce a deep plane of
anesthesia throughout the experiment. During surgery and experimentation, the
rat was placed within a stereotaxic frame fitted with an adjustable arm and incisor
bar (David Kopf Instruments, Tujunga, CA). Body temperature was maintained at
37°C with the aid of a re-circulating heating pad (Gaymar Industries, Orchard
Park, NY) that was placed underneath the animal. The rat’s eyes were coated
with artificial tears (Medivet.com, #11970) to prevent dryness. Fur overlying the
surgery site was shaved and the scalp was cleaned three times with alternating
solutions of 70% isopropyl alcohol and povidone-iodine topical antiseptic. A 3 cm
longitudinal incision was made over midline through the scalp to expose the skull.
Skin and fascia were retracted with clamps. A craniotomy (4 x 6 mm) was
performed over the hippocampal formation in each hemisphere. The dura was
carefully pierced and dissected away to expose the cortical surface of the brain.
A small burr hole was drilled over the left PFC for placement of an Ag/AgCl
reference electrode. At regular intervals (20-30 minutes), saline solution (0.9%,
pH = 7.4) was irrigated through the surgical site to flush away blood and debris,
and to prevent drying of exposed brain matter.

2.3.2 Studies in Unanesthetized Animals
One day before surgery, animals received a subcutaneous injection of 5
mg/kg Rimadyl® (Carprofen, Pfizer Animal Health Products) to alleviate postoperative pain. Anesthesia was induced by placing the rat in a sealed chamber
filled with a 2% mixture of Isoflurane (Baxter Healthcare, IL) and oxygen, after
which the rat was transferred to a stereotaxic frame fitted with an anesthesia
nose mask, adjustable arm and incisor bar (David Kopf Instruments, Tujunga,
CA). Surgery was performed in a disinfected vertical laminar flow workstation
(Microzone Corp., Ontario, Canada), using sterile surgical instruments. The rat’s
eyes were coated with artificial tears (Medivet.com, #11970) to prevent dryness
and infection. Fur overlying the surgery site was shaved. The scalp was cleaned
three times with alternating solutions of 70% isopropyl alcohol and povidone-

26

iodine topical antiseptic. An incision (1.5 – 2.0 cm) was made along midline
through the scalp to expose the skull overlying the hippocampus. The incised
skin was retracted with clamps and the fascia was carefully moved aside. A
craniotomy (3 mm x 3 mm) was performed over the right hippocampus. The dura
was carefully dissected away to expose the cortical surface of the brain. Burr
holes were drilled into the frontal cortex and left hippocampus for placement of
three stainless steel bone screws (outer diameter = 0.5 mm). For glutamate
recording studies, an additional burr hole was drilled for placement of a miniature
Ag/AgCl reference electrode. After the skull was fitted with bone screws, the
MEA assembly was slowly lowered into the brain at an approximate rate of (0.1
mm∙s-1). The retraction clamps were removed and the entire surgical site was
filled with a mixture of fast-setting cold cure dental cement (Lang Dental
Manufacturing Co., Inc.) which adhered tightly to the skull screws. Additional
dental cement was used to cover the MEA implant and close the surgery site.
The entire surgical procedure lasted for approximately 1.5 hours.
Just before withdrawing anesthesia, rats received a subcutaneous
injection of 3 ml saline and 5mg/kg Rimadyl®. Animals were placed on a heated
pad to help maintain body temperature until fully conscious. For two days post
surgery, a soft food diet was provided. Rimadyl® and saline were given as
needed for management of post-operative pain and dehydration. Animals were
monitored everyday for weight loss, distress, infection and problems with healing
of the surgery site. For long term studies, the animal’s health was routinely
evaluated. Rats exhibiting prolonged discomfort or infection were euthanized
immediately with an overdose of isoflurane anesthetic (5%) followed by
decapitation and were excluded during data analysis. Overall, the surgical
procedure was tolerated extremely well, indicated by a minimal loss of body
weight (<5%) post-surgery.
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2.4 Euthanasia and Tissue Recovery
At the end of an experiment, urethane-anesthetized rats underwent
transcardial perfusion with 120 ml of saline followed by 60 ml of 4%
paraformaldehyde. Rats used for freely moving studies were first anesthetized
with isoflurane (5%), and then euthanized by transcardial perfusion. Depending
on the type of study, brains were processed either for MEA placement verification
(Figure 2.6) or histological analyses.

2.5 In Vivo Amperometry Using Ceramic-based MEAs
2.5.1 MEA Design and Fabrication
For a detailed description of design and fabrication procedures please
refer to Burmeister et al (2000) and Hascup et al (2006). MEAs were
manufactured on a large scale with high reproducibility using a series of
photoresist layers and coating masks (Hybrid Circuits Inc., Sunnyvale, CA).
Figure 2.1 illustrates the photolithographic procedure. High density fabrication
was achieved by patterning multiple MEAs onto a single ceramic (Al2O3) wafer
(Coors Ceramic Co., Golden, CO) measuring 2.5 cm x 2.5 cm X 37.5 µm.
Ceramic substrates are known for rigidity, durability and inertness, making them
a good choice for use as an indwelling implant. The 99% pure Titanium and
Platinum layers were deposited onto the wafer to define recording sites,
connecting lines, and bonding pads. With the exception of the Pt sites, all
circuitry was protected from aqueous environments by spin-coating polyimide
onto the surface. Recently this process has been improved by vacuum deposition
of the polyimide, making it an integral component of the MEA surface. A diamond
saw was used to pattern MEA tips with smooth edges (Hybrid Circuits, Inc.,
Sunnyvale, CA), a significant advancement over previous laser-cutting methods.
For the work presented in this dissertation, we utilized a novel MEA design
(W4 MEA), comprised of four Pt surfaces (20 X 150 μm) arranged in dorsal-

28

ventral pairs (Figure 2.2 A). The total recording area of this design is
approximately 40% smaller than our standard MEA design. Detailed parametric
studies have shown that the recording performance of the smaller Pt sites is
comparable to our standard MEA. This geometry is ideal for targeted
measurements in the DG, CA3 and CA1 subregions of the rat hippocampus.
MEAs intended for use in anesthetized animals were attached to a printed circuit
board (PCB) that was fitted with connections to the amperometric recording
instrumentation (Figure 2.2 B). A shortened PCB was used for studies in
unanesthetized animals (Figure 2.2 C). All assembled MEAs underwent intensive
cleaning before in vivo use.
2.5.2 Amperometric Recording Instrumentation
A potentiostat (FAST16mark II system, Quanteon L.L.C, Nicholasville, KY)
was used to maintain a constant voltage of +0.7 V between the Ag/AgCl
reference electrode and the working sites of the MEA. Current generated at the
Pt recording sites was recorded at sampling rates of 2 or 10 Hz. Current-tovoltage converters had a final gain of 2 pA·mV-1 for all experiments. The stored
data was analyzed offline using custom designed Microsoft Excel spreadsheet
and Matlab®-based software (courtesy Jason Burmeister, 2009).

2.6 Glutamate Measurements in Anesthetized Rats
2.6.1 MEA Preparation
W4 MEAs were prepared for in vivo use as described in our previously
published methods (Burmeister et al., 2002; Hascup et al., 2006, Thomas et al.,
2008). Since glutamate is non-electroactive, it is necessary to modify the Pt
recording sites with glutamate oxidase coatings that allow for detection of
glutamate. An enzyme solution of 1% glutamate oxidase, 1% bovine serum
albumin and 0.125% gluteraldehyde was manually applied to the lower pair of Pt
sites (marked A in Figure 2.3) for glutamate measurements. The ‘sentinel’ site
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pair (marked B in Figure 2.3) was similarly coated with an inactive protein of
bovine serum albumin and gluteraldehyde without glutamate oxidase. This type
of differential coating technique allowed for the validation of true glutamate
signals though self-referenced signal comparisons with the sentinel sites.
Coatings were cured for 48 hours to improve immobilization of the enzyme matrix
to the Pt recording surfaces. Immediately prior to in vitro calibration, 1, 3phenylenediamine (poly-mPD) was electropolymerized onto all Pt surfaces to
create an interferent exclusion layer against electroactive molecules such as
ascorbate, dopamine and DOPAC (Friedemann et al., 1996). The resulting polymPD matrix permitted diffusion of small molecules like NO and H2O2 (Figure 2.3).
2.6.2 In Vitro Calibration and MEA Selection Criteria
Calibrations were performed to determine the performance of MEAs by
comparing the recording characteristics of each Pt site with standard criteria.
Data obtained during calibration was used to correct slight differences between
Pt sites caused either during photolithography or due to differences in the quality
of manually applied coatings. During calibration, the MEA tip was submerged in
0.05 M phosphate-buffered saline (40 ml stirred solution, pH 7.4, 37°C) and
maintained at a constant potential of +0.7 V vs. an Ag/AgCl reference by the
FAST16mkII system. A standard response curve was generated by adding
successive aliquots of 20 mM glutamate solution to produce final beaker
concentrations of 20, 40 and 60 μM (Figure 2.4). The resulting increase in
oxidation current (nA) was used to determine the coefficient of calibration that
equated an observable change in electron current to a known change in
glutamate concentration (Burmeister and Gerhardt, 2001). The slope (nA·µM-1) of
the standard response curve was used to calculate the limit of detection for
glutamate signals (LOD) which is the most important parameter for determining
MEA usability. Note that a change in current was determined to be a signal only
if the change in amplitude was at least 3 times greater than the root mean
squared noise on the baseline current. MEA selectivity (ratio of glutamate
molecules measured per molecule of ascorbate) was determined using a 250 μM
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ascorbic acid challenge. At the end of calibration, MEA sites were exposed to 2.0
µM Dopamine to confirm the interferent blocking capacity of the mPD layer (also
a negative control) and 8.8 µM H2O2 to test the responsiveness of each working
site (positive control). Sites were also tested for sensitivity to intracranial
solutions to avoid false positive measurements in vivo. Standard selection criteria
for W4 MEAs were defined as: Slope≥ 5 pA·µM
Selectivity ratio≥ 20:1

-1

, limit of detection ≤ 1.0 µM,

(glutamate:ascorbic acid) and response linearity to

glutamate ≥ 0.997.
2.6.3 Experimental Setup for Glutamate Recordings
A pre-pulled glass micropipette (internal diameter: 0.58 mm, A-M Systems
Inc., Everett, WA) was attached to the PCB holder such that the tip (internal
diameter: 10 - 12 μm) of the micropipette was 70 ± 10 μm away from the MEA
surface, between all four recording sites. Through this micropipette, solutions of
KCl (70 or 120 mM; Day et al, 2006) or glutamate (100 μM prepared in 0.09%
Saline) were delivered to study stimulus-evoked glutamate overflow and
extrasynaptic glutamate clearance in the DG, CA3 and CA1 fields of the rat
hippocampus. A Picospritzer II pressure ejection system was used to control
solution volumes by adjusting the applied pressure (5–20 psi) for a fixed period of
time (0.5 s).
Stereotactic coordinates for DG, CA1 and CA3 were calculated using the
rat brain atlas of Paxinos and Watson (2005) where anterior–posterior (AP),
medial-lateral (ML) and dorsal-ventral (DV) measurements were taken from
bregma, midline and surface of the skull, respectively (refer to Table 2.1 for exact
coordinates; locations shown in Figure 2.6). The subregions were targeted in
random order during experiments to avoid bias. A microdrive attached to a
stereotaxic arm was used to lower the MEA/micropipette assembly into the
hippocampus until the center of the lower site pair was aligned with the tissue
coordinates for each subregion. A miniature Ag/AgCl reference electrode was
inserted in the left pre-frontal cortex to complete the electrochemical circuit. Note
that the curved anatomy of the hippocampus made it possible to measure
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glutamate from the CA1 and DG at the same AP and ML coordinates at different
depths.
2.6.4 Resting Glutamate Measurements
All glutamate measurements were taken during the light phase. A key
benefit of our MEA design is the use of ‘sentinel’ recording sites for selfreferencing. The sentinels are identical to the recording MEA except for the
oxidase enzyme layer. As a result, data from the sentinel sites can be used to
detect and remove undesirable molecules by subtracting the response of the
sentinel sites from the primary recording sites. This subtraction technique is
analogous to the working principle of spectrophotometry. Using this dual-channel
recording strategy, the oxidation current on the sentinel sites is subtracted from
the oxidation current on the working sites to determine current corresponding to
glutamate. This current is divided by the MEA calibration curve (from calibration)
to obtain true resting glutamate concentrations in hippocampal subregions
(Figure 2.5)
2.6.5 Stimulus Evoked Glutamate Overflow
At each tissue location, baseline glutamate measurements were acquired
for at least 15 minutes prior to intracranial application of solutions. Phasic release
of glutamate was produced by applying nanoliter volumes (12.5 – 150.0 nL) of
low concentration KCl (70 mM KCl, 2.5 mM CaCl2, 79 mM NaCl) or high
concentration KCl (120 mM KCl, 2.5 mM CaCl2, 35 mM NaCl) into the DG, CA3
or CA1 subfields (n = 7 for each subregion, nANIMALS = 21). Solution volumes
were determined by measuring fluid displacement in the micropipette with a
zoom capable stereomicroscope fitted with a calibrated reticule (Cass et al, 1992;
Friedemann and Gerhardt, 1992). A dose response study was used to obtain
reproducible glutamate signals and determine maximum glutamate release in
each subregion.
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2.6.6 Clearance of Locally Applied Glutamate
Clearance of physiologically relevant quantities of glutamate was studied
by applying an exogenous solution of 100 μM glutamate (n = 6 for each region,
nANIMALS = 17). This allowed us to study clearance of glutamate at a
physiologically relevant concentration, and offered the benefit of isolating
glutamate clearance mechanisms. This is distinct from studying glutamate
clearance following KCl-evoked release, because potassium depolarization of
neurons causes a non-selective release of neurochemicals, such as GABA or
other potentially modulatory molecules. Application of exogenous glutamate also
allowed for control of KCl effects on glutamate transporters.
Average evoked glutamate release observed across all hippocampal
regions from KCl studies was used to determine the volume (12.5 – 75.0 nL) and
amplitude range of locally applied glutamate. Glutamate clearance capacity was
analyzed in terms of uptake rate (expressed as the product of (AmplitudeMAX) and
first order rate of signal decay k

-1

(s-1), or T80 (time taken for signal to decay by

80% from maximum amplitude) (Figure 2.5).
2.6.7 Depth Profile Investigations of Glutamate Neurotransmission
A hippocampal depth profile of resting glutamate was obtained by
positioning the MEA tip in the stratum oriens of the CA1 and lowering it by -0.35
mm to target the stratum radiatum of the CA1 as well as the suprapyramidal
molecular layer, polymorphic layer and infrapyramidal layer of the DG subregion.
Regional variations in phasic glutamate were determined by targeting the
MEA to the suprapyramidal stratum oriens of CA1. Once stable baselines values
were reached, phasic glutamate release in response to 70 mM KCl stimulation (a
total of 5 ejections applied after two minutes) was investigated. Next, the MEA
was lowered by a distance of 0.35 mm to reach the suprapyramidal stratum
radiatum of CA1. As before, phasic glutamate was determined. This process was
repeated three more times to obtain glutamate measurements for the
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suprapyramidal molecular layer, the dentate hilus and infrapyramidal molecular
layer of DG.
2.6.8 MEA Placement Verification
At the end of each experiment, rats were euthanized as described in
section 2.4. Paraformaldehyde fixed hippocampal tissues were sectioned using a
cryostat (30 µm) and stained with cresyl violet to verify placement of the MEA
tracks.
2.6.9 Data Analysis and Statistics
Resting glutamate values obtained from left and right brain hemispheres
were averaged and reported as one measurement per region per rat (n = 30).
Glutamate signal data obtained from local application of KCl in the DG, CA3 and
CA1 hippocampal subregions was recorded by the FAST16mkII system. Signal
parameters were analyzed offline with custom-created Matlab® software
(courtesy Jason Burmeister, 2009). For comparison purposes, data from a given
subregion was included in the analysis only if the signal could be reproduced
three times. Volume-matched and amplitude-matched glutamate signals were
selected from each region to determine maximum increase (μM) in stimulusevoked glutamate concentration from baseline values (AmplitudeMAX), and the
time, TRISE (s), time to reach AmplitudeMAX. As mentioned above, glutamate
clearance capacity was analyzed in terms of uptake rate (expressed as the
product of (AmplitudeMAX) and first order rate of signal decay k

-1

(s-1), or T80

(time taken for signal to decay by 80% from AmplitudeMAX).
It is important to note that glutamate signals could not be obtained from
every region for each animal due to a depression of signals following repeated
KCl ejections. Accordingly, paired comparisons were not conducted. For
statistical comparisons, a one-way analysis of variance (ANOVA, significance
defined as p<0.05) along with Tukey-Kramer post-hoc tests (GraphPad Prism
5.0) were performed.
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2.7 Glutamate Measurements in Unanesthetized Rats
2.7.1 Chronic MEA/Cannula Assembly
For these experiments, a modified PCB design was used for all recordings
(Figure 2.2 D). Recording sites of all MEAs were coated with Nafion and dried
at 175°C for 4 minutes for improved selectivity. Nafion® has a net negative
charge; therefore it repels anionic interferents such as ascorbic acid and DOPAC
(Gerhardt et al., 1984). Parametric studies demonstrated greater stability for
Nafion® in comparison to mPD during chronic experimentation (Hascup,
unpublished data). Similar to section 2.6, MEAs were configured for selective
glutamate detection. Circuit connections for the recording sites and a miniature
Ag/AgCl reference electrode were soldered to a modified pedestal connector
(Ginder Scientific, Ottawa, Ontario) and insulated with epoxy glue, previously
described by Rutherford et al (2007). A 26-gauge stainless steel guide cannula
(Plastics One, Roanoke, VA, USA) was affixed to the ceramic paddle at a
distance of 60 µm with sticky wax (Kerr Corp., Orange, CA) to allow local
application of exogenous solutions. During experimentation, an internal cannula
was inserted into the guide. At other times, a solid stainless steel dummy cannula
remained in the guide.
2.7.2 In Vitro Calibration and MEA Selection Criteria
MEA performance was determined via in vitro calibration (described in
section 2.6). MEAs were required to demonstrate sensitivity values > 2.2 pA∙μM

-

1

, selectivity values of at least 20:1 LOD values < 1 μM to qualify for in vivo use.

2.7.3 Experimental Setup for Glutamate Recordings
Following surgery, all animals were allowed to recover for three days
before experimentation.

On the day 4, rats were transferred to a recording

chamber with a commutator coupled to a miniature current-to-voltage converter
headstage (Quanteon, LLC, Nicholasville, KY) and connected to FAST16mkII
instrumentation. This allowed animals to move with minimal restriction.
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2.7.4 Resting Glutamate Measurements
Animals were acclimated to the recording chamber for approximately 30
minutes and then connected to the miniature current-to-voltage converter and
recording instrumentation. In general, a baseline glutamate signal was obtained
after 2.5 – 4 hours. Resting glutamate was measured on days 4, 5 and 6 postsurgery. In addition, MEA functionality was confirmed by local application of 2.5
µl of 1 mM glutamate through the cannula system.
2.7.5 Data Analysis
For all animals, tonic glutamate measurements obtained on days 3 and 4
were averaged and reported as a single value. A Grubb’s test did not identify
any significant outliers and all animals were included in the final analysis. Tonic
glutamate levels in the DG, CA3, and CA1 hippocampal subregions were
discretely compared across age groups using one-way analysis of variance tests
(ANOVA) followed by Bonferroni’s post-hoc test. Statistical significance was
defined as p < 0.05.

2.8 Scanning Electron Microscopy Studies of MEAs
A schematic of a scanning electron microscope is shown in Figure 2.7.
Electron microscopy imaging of MEAs (n = 25) was carried out at the University
of Kentucky Advanced Science and Technology Commercialization Center
(ASTeCC). A Hitachi S3200 variable pressure scanning electron microscope
(SEM) was used to capture high resolution electron micrographs in two separate
modes: secondary electron imaging (SEI) and backscattered electron detection
(BSE). The former was used to capture surface features with high spatial
resolution while the latter was used to detect changes in surface composition.
The MEA was loaded onto a rigid specimen holder called a stub, using a graphite
adhesive to assist with charging of the sample surface. Though non-conductive
specimens can be observed in the SEM, we metalized the ceramic surface with a
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coating of Gold/Palladium alloy to maximize spatial resolution (up to 250,000X) of
the signal and prevent accumulation of static electrical charge during exposure to
the electron beam. The operation parameters were defined as: Accelerating
voltage 20 keV, Working distance 15 mm and Beam current of 43 µA. Electron
micrographs of the MEA surface were digitally captured, displayed and stored
with Quartz PCI software.

2.9 Atomic Force Microscopy Studies of MEAs
We studied the surface topography of the ceramic surface, Pt recording
site and polyimide coating of the W4 MEAs using atomic force microscopy
(AFM). The AFM probe used in these experiments was a standard contact-mode
uncoated silicon tip (Ted Pella Inc., Redding, CA) with a tip radius of
approximately 10 nm and a half cone angle of 20° to 25° (measured along the
cantilever axis). The MEA sample was studied at room temperature at normal
atmospheric pressure. The microscope used in these studies (Digital
Instruments/Veeco Nanoscope) maintained a fixed probe position but moves the
sample underneath the cantilever at a fixed scan rate of 2.4 Hz in a rastered
fashion to obtain a three dimensional profile of the surface of interest. The area
of the sample surface was either 1 nm2, 15 nm2 or 20nm2. Topography data for
each sample (n = 3) was obtained three times. Following AFM experimentation,
representative three dimensional images were constructed to visualize the
topography of each component (ceramic, Pt and polyimide). Images constructed
in perspective view illustrated the shape and general distribution of peaks and
holes across the sampled region while images shown in profile view emphasize
feature to feature variability in lateral spread and vertical displacement. In all
images, the height scale and deflection range was adjusted to optimize the
presentation of topographical information.
To quantify the AFM data, we conducted a roughness analysis for each
recording site (NSITES = 2, NITERATIONS per site = 3) using scanning probe imaging
processor, also known as SPIP software (Imagemet Metrology A/S, Denmark).
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For the present study, roughness analysis values obtained for multiple sample
iterations were averaged and reported as a single value for each parameter.
Note that there were no significant differences between iterations for a given
surface. This included calculations of average roughness (RAVG, the arithmetic
average of absolute values of peaks and valleys within the selected area), root
mean squared roughness (RRMS), surface symmetry (RSKEW, dimensionless
number signifying the relative proportion of peaks and valleys), maximum peak
height (HMAX) and maximum valley depth (DMAX, absolute distance) within the
sampled surface. Sudden changes in sample height, say, at the boundary of a
site or the edge of the ceramic base were expected to skew roughness values
therefore these portions of the image were excluded during analysis. In addition,
a height distribution of the sample surface was obtained. Finally, multiple linescans of the surface were performed as a qualitative assessment of surface
roughness.

2.10 Magnetic Resonance Imaging of the Brain – MEA Interface
Please refer to the section on animal preparation for unanesthetized
studies for details of the implantation procedure. Magnetic resonance imaging
was performed immediately following surgical insertion of the chronic MEA to
characterize hippocampal tissue response. To ensure MR-compatibility of the
surgical site, the MEA assembly was cemented in place without steel bone
screws. Because this requirement results in an unstable implant, the animal was
euthanized immediately after the experiment. Urethane anesthesia was used to
minimize movement related disruptions during imaging. T1-weight images were
obtained to maximize visualization of fluid changes in the extracellular matrix
surrounding the MEA. For this study we used using a Siemens Trio imager with
Echo Time (TE) set at 2.6 ms, Repetition Time (TR) set at 25.0 ms and the Flip
Angle (AF) set to 60º.
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2.11 Inkjet-based Microprinting Technology for Application of Enzymes on
MEA Recording Sites
2.11.1 Principles of Piezoelectric Inkjet Printing
Piezoelectric jetting devices consist of a fine nozzle enclosed by an
electromechanical element, such as a Piezo crystal. Application of a controlled
intermittent voltage pulse causes mechanical deformation of the crystal element,
forcing the release of fluid droplets through the nozzle (Figure 2.8). This basic
principle is utilized in commercial and industrial inkjet-based devices to print predefined patterns onto a variety of substrates.
Figure 2.9 is a schematic representing the main components of the
Jetlab® 4 microprinting station (Microfab Technologies, Plano, TX). Briefly, the
printing assembly is comprised of an array of piezoelectric jetting devices
(MicroJets®, Microfab Technologies, Plano, TX) and the fluidic and electrical
components necessary for driving the ejection of droplets from the jetting
devices. It also contains translation stages to control substrate position in the x-,
y- and z- directions (Sutter Instrument Company, Novato, CA), and a
visualization system for controlling the droplet placement. The jetting device is a
capillary glass tube pulled to an orifice diameter of 50 µm and encased inside a
piezoelectric transducer and protective metal housing. Appropriate backpressure
regulation is critical for stable droplet formation. Therefore, a pneumatics
controller (MicroFab Technologies, Plano, TX) and pressure/vacuum pump (Gast
Manufacturing, Benton Harbor, MI) are also integrated into the printing system.
Custom-coded LabView® software (National Instruments, Austin, TX) is used to
control both the stage motion and inkjet printing functions. All jetting parameters,
including pulse generation, number of droplets dispensed per pulse, droplet
spacing and printing sequence can be controlled through the software program.
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2.11.2 Preparation of Printing Assembly
At the start of an experiment, an intensive cleaning procedure was used to
clean the entire dispensing system. Briefly, filtered solutions of Micro-90
detergent solution (2% v/v, Fischer-Scientific), hot water and 70% isopropyl
alcohol were flushed through the jetting device and attached tubing. This is an
important step that minimizes clogging of the device during printing trials. Except
for the coating solutions, all fluids were through a 5 µm syringe filter (Fisher
Scientific) prior to filling the reservoir to the jetting device. Droplets leaving the
nozzle were viewed on a computer monitor. Illumination and tracking of picoliter
sized droplets was made possible by imaging software connected to a strobed
LED, a movable camera (Thales Optem, Fairport, NY), and a DVD recorder
(Panasonic, Secaucus, NJ). Once a steady vertical stream of water droplets
could be visualized in continuous jetting mode, the device was ready for use.
2.11.3 In Vitro Testing of Coated MEAs
For our optimization studies, we used choline oxidase and xanthine
oxidase as test enzymes because they are relatively inexpensive in comparison
to glutamate oxidase but are similar to it with respect to in vitro and in vivo
behavior. Coating quality was tested by in vitro calibration. This has been
described in detail in section 2.6. Since electrode sensitivity and limit of detection
were the only parameters of interest, an exclusion layer was not applied on these
MEAs.

2.12 Immunohistochemical Analysis of Brain Tissue and MEAs following
Chronic Implantation
Please refer to section 2.3 for details on surgical procedures for
unanesthetized animal studies. The purpose of these studies was to evaluate the
biocompatibility of our current MEA design and materials for long term
implantation in the rat hippocampus. Therefore rats were implanted with W4-
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MEAs modified for chronic studies (Figure 2.2 C). Since glutamate recordings
would not be taken for these experiments, we used non-functional MEAs lacking
enzyme coatings.
Rats with chronic MEA implants in the CA3 subregion of the hippocampus
(n = 5 per group) were euthanized at 1 or 3 days and 1, 8, 16, or 24 weeks via
transcardial perfusion with 4% paraformaldehyde. Three animals were excluded
from the study at the time of euthanasia due to infection at the surgery site. Two
additional animals were removed following tissue analysis. One showed severe
hemorrhaging while in the other the probe was not positioned in the
hippocampus but had followed along the corpus callosum. Three animals were
euthanized in the middle of the study because of a dislodged head-cap. Further,
we excluded control values from animals that had a cavity in the cortex
attributable to the bone screws where inflammation had followed. More detailed
description of these tissues is not included as these results appeared to be due
to handling of the probes and the procedures used during insertion and wound
closure. Since refinement of surgical methods and experience reduces these
complications, the effect of these factors on long term MEA presence is not
discussed. The present study, therefore, is limited to tissues from animals in
which the surgical and insertion procedures did not appear to produce any gross
complications. Thus, there were 5 animals at 8 weeks and 6 months, 4 animals
at 1 day and 4 months, and 2 animals at days 3 and 7.
During tissue processing, implantation times were blind-coded so as to not
bias the study in any way. Brains and MEAs were removed, stored in 4%
paraformaldehyde for three days, and then transferred to buffer solution
containing 0.1 M phosphate with 10% sucrose and 0.01 M bacitracin until ready
for processing. MEAs underwent immunohistochemical analysis to account for
tissue detachment during removal. Tissue sections (14 μm thickness) adjacent to
the implant track were obtained using a cryostat (courtesy Dr. Ingrid Strömberg,
Umeå University, Sweden). MEAs and tissue sections were fixed in acetone for 3
minutes, followed by two incubation periods, each with a different primary
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antibody, for 48 hours at 4°C. For this study, we chose antibodies selective for
astrocytic glial fibrillary acidic protein (anti-mouse GFAP, diluted 1:400;
Chemicon) and microglia (anti-rabbit Iba1, diluted 1:1000; Wako Chemicals,
Germany). Next, the samples were rinsed and incubated for 1 hour at 25°C in a
solution containing Alexa 488 and Alexa 594 secondary antibodies respectively
(diluted 1:500 with PBS containing 0.3% Triton-X, Molecular Probes). After
additional rinsing, samples were mounted onto slides with a drop of 90% glycerin
in PBS. Immunohistochemical images were evaluated using Improvision software
(Source: NIH). The densities of GFAP and Iba1 Immunoreactivity were calculated
using NIH image software and expressed as mean gray density. Values obtained
from four tissue sections of each rat were averaged to obtain one number.
Averaged numbers for each time point were analyzed using a one-way ANOVA
followed by Dunnet’s post hoc test. Significance was defined as p < 0.5.

2.13 Drugs and Reagents
Unless otherwise stated, drugs and reagents were used as received.
Calcium chloride dihydrate, Citrisolv™, ethanol (70%), isopropyl alcohol, Micro90 Cleaning solution, paraformaldehyde, phosphoric acid, potassium chloride,
sodium chloride, sodium hydroxide, sodium dihydrogen phosphate, sodium
hydrogen phosphate and Urethane were obtained from Fisher Scientific (Fair
Lawn, NJ). Hydrogen peroxide (3% H2O2 topical solution) was purchased from
Rite Aid. L-glutamate oxidase was purchased from Seikagaku America, Inc.
Ascorbate, bovine serum albumin (fraction IV), Congo red dye, cresyl violet dye,
Fast Green dye, Gluteraldehyde (25%), 3-Hydroxytyramine hydrochloride
(Dopamine, DA), L- glutamate monosodium salt, Nafion® (5% in a mixture of
aliphatic alcohols and water) and 1, 3-phenylenediamine dihydrochloride (mPD)
were obtained from Sigma (St Louis, MO). Isoflurane and Rimadyl™ (Carprofen)
were provided by the University Of Kentucky Division Laboratory of Animal
Resources. The molecular stoichiometry for the above-described molecules was
selected on the basis of detailed parametric studies. All solutions were prepared
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using distilled, deionized water. Solutions prepared for in vivo applications were
passed through a 0.22 µm filter (Costar, Corning, NY) to minimize particulate
obstruction of the micropipettes.
Copyright © Pooja Mahendra Talauliker 2010
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Figure 2.1: MEA fabrication using photolithography
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Figure 2.1 (contd.): MEAs are manufactured with high reproducibility using a
series of photoresist layers and coating masks. The 99% pure Titanium and
Platinum layers are deposited onto the wafer to define recording sites,
connecting lines, and bonding pads. With the exception of the Pt sites, all
circuitry is protected from aqueous environments by spin-coating polyimide onto
the surface. Lastly, a diamond saw was used to pattern MEA tips with smooth
edges. (Figure adapted from Burmeister et al., 2001)
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Figure 2.2: W4-MEA configured for neurotransmitter recordings in
anesthetized and unanesthetized animals. Panel A is a schematic of the W4
MEA. The Pt sites (20 μm х 150 μm) arranged in dorsal-ventral pairs, allowing for
accurate targeting of DG, CA3 and CA1 subregions. Panel B is a photograph of a
W4-MEA bonded to a PCB. A glass micropipette is positioned between the four
Pt sites at a distance of 60 – 80 µm for local application of intracranial solutions.
Panel C shows a W4-MEA with a modified PCB for chronic studies in
unanesthetized rats. For glutamate recordings, a stainless steel cannula system
is attached between to the MEA tip with Kerr wax (Panel D).
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B

A

Figure

2.3:

W4

MEA

configured

for

self-referenced

glutamate

measurements. Poly-metaphenylenediamine (poly-mPD) acts as a sizeselective exclusion layer against electroactive interferent molecules such as
Ascorbate, Dopamine and DOPAC. Site pair A was configured for glutamate
detection with a manual coating of glutamate oxidase (GluOx), bovine serum
albumin (BSA) and gluteraldehyde (Glut). Site pair B was coated with an inactive
solution of BSA and Glut. Enzymatic breakdown of glutamate produces hydrogen
peroxide (H2O2) ‘reporter’ molecules. Current (at +0.7 V vs. Ag/AgCl reference
electrode) from glutamate is determined by subtraction of current measured by
Site pair B from Site pair A. This recording strategy is known as self-referencing.
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Figure 2.4: Calibration of W4-MEAs. The tip of the MEA is submerged in 0.05
M PBS (40 ml stirred solution, pH 7.4, 37°C) and maintained at +0.7 V vs. an
Ag/AgCl reference electrode. A standard response curve is generated by adding
serial aliquots of 20 mM glutamate solution to produce final beaker
concentrations of 20, 40 and 60 μM. The resulting increase in oxidation current
(pA) is used to determine the slope (nA·µM-1) of the curve and the limit of
glutamate detection (3 x RMS noise on the baseline signal). MEA selectivity is
determined using a 250 μM ascorbic acid challenge. At the end of calibration,
recording site sensitivity (or lack thereof) to Dopamine (DA) and hydrogen
peroxide (H2O2) was verified (negative and positive controls, respectively).

48

Figure 2.5: Signal characteristics for MEAs. Extracellular glutamate
concentration (μM) is calculated by subtracting the current measured by the
‘sentinel’ sites from glutamate oxidase (GluOx) coated sites, and dividing the
difference by the slope of the GluOx site (obtained during calibration). This is
useful for obtaining resting levels of glutamate (GlutamateRESTING), maximum
increase in glutamate concentration following local application of KCl solution
(AmplitudeMAX), and the rate of glutamate clearance (Uptake rate = k-1 x
AmplitudeMAX ). Clearance is also measured in terms of time (s) to signal decay,
for e.g., time taken for signal to decay by 80% from maximum amplitude, or T80.
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Figure 2.6: Electrode placement verification in the rat hippocampus. Cresyl
violet stained sections showing the location of the electrode track in the CA1 (A),
CA3 (B) and DG (C) respectively.
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Figure 2.7: MEA surface imaging using scanning electron microscopy.
Electrons emitted by the heated tungsten filament are focused and redistributed
by a series of lenses and coils to allow scanning of a sample surface in a raster
fashion. When the electron beam interacts with the ceramic surface,
displacement of secondary electrons located a few nanometers beneath the
sample surface is measured by a secondary electron detector. For viewing
purposes, scanning data of the imaged surface is amplified, digitized and
expressed in terms of variations in gray levels. (Figure adapted from
Encyclopedia Brittanica, 2008)
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Figure 2.8: Basic properties of piezo-based inkjetting of solutions.
Application of a controlled intermittent voltage pulse causes mechanical
deformation of the crystal element, forcing the release of fluid droplets through
the nozzle.
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Figure 2.9: Schematic illustration of JetLab4 microprinting system. The
Jetlab® 4 microprinting station (Microfab Technologies, Plano, TX) printing
assembly is comprised of an array of piezoelectric jetting devices (MicroJets®,
Microfab Technologies, Plano, TX) and the fluidic and electrical components
necessary for driving the ejection of droplets from the devices. It also contains
translation stages to control substrate position in the x, y and z directions (Sutter
Instrument Co., CA), and a visualization system for controlling droplet placement.
The jetting device is a capillary glass tube pulled to an orifice diameter of 50 µm
and is encased inside a piezoelectric transducer and protective metal housing. A
pneumatics controller (MicroFab Technologies, Plano, TX) and pressure/vacuum
pump (Gast Manufacturing, Benton Harbor, MI) is integrated into the system for
regulation of backpressure regulation. All jetting parameters can be controlled
through the software program. (Image adapted from Lei et al., 2002).
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Table 2.1 Stereotaxic Coordinates for Hippocampal Subregions
Anterior -

Medial –

Dorsal –

Posterior (mm)

Lateral (mm)

Ventral (mm)

Dentate Gyrus
(DG)

-4.0 ± 0.2

± 3.0 - 3.3

-3.6 ± 0.2

Cornu Ammonis 1
(CA1)

-4.0 ± 0.2

± 3.0 - 3.3

-3.0 ± 0.2

Cornu Ammonis 3
(CA3)

-4.0 ± 0.2

± 3.5 - 3.8

-4.0 ± 0.0

Average animal weight = 300.0 g ± 28.0 g
n = 7 for each subregion, nANIMALS = 21
Obtained from Paxinos and Watson, 2005
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Chapter Three: Real-time Measurements of Glutamate Neurotransmission
in the Hippocampal Trisynaptic Pathway of F344 Rats

3.1 Introduction
During the past three decades, the hippocampus has been intensively
studied for its vital role in cognitive learning and memory formation. Though
much is known about the structural and functional properties of neurons localized
to this brain region, an understanding about how afferent information to the
hippocampus is processed at a cellular level and encoded as a new memory or
learned behavior is necessary (for review, see Szapiro et al., 2002; Richter and
Klan, 2009). The hippocampus is susceptible to a number of physiological and
functional changes during aging (Segovia, 2001) and is one of the first structures
to be affected during age-related onset of Alzheimer’s disease (Francis et al.,
2003; Armstrong et al., 2003). It is also extremely vulnerable to tissue damage
from hypoxic-ischemic injury (Ashton et al., 1989; Leifer and Kowall, 1993) and
recurrent seizures (Meldrum and Chapman, 2000; Chapman et al., 2001). To aid
the development of diagnostic tools and appropriate treatment paradigms for this
important brain region, knowledge about the molecular mechanism(s) involved in
these pathologies is also needed.
Glutamate is the dominant excitatory neurotransmitter in the brain and
hippocampus (Danbolt, 2001). Cellular communication between principal
hippocampal neurons is excitatory, mediated by ionotropic glutamate receptors of
AMPA and NMDA-sensitive subtypes (for review see Malenka and Nicoll, 1993).
These receptors also mediate long-lasting changes in synaptic strength through
a process termed long term potentiation or LTP (Andersen et al., 2007). LTP is
widely suggested to be the anatomical substrate for cognitive learning, while the
resulting change in the synapse has been hypothesized to represent encoded
‘memory’ (Angulo et al., 2004; Albensi et al., 2007). Metabotropic glutamate
receptors (mGluRs) have also received significant attention for their modulatory
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effects on LTP (Anwyl, 1999, 2009) and long term depression (LTD) (Kemp and
Bashir, 1999).
It is important to note that glutamate is regulated by a highly efficient
uptake system. This ensures precise activation of glutamate’s post-synaptic
targets (Sonnewald, Westergaard and Schousboe, 1997). Overexposure to
glutamate through uncontrolled release or loss of

effective clearance

mechanisms causes a pattern of neuronal death and tissue damage that is
uniquely identifiable in histological tissue sections (Martin et al., 1998).
Particularly in the hippocampus, excitotoxic damage is a hallmark of recurrent
seizure activity and thought also to be a large contributor to hypoxic-ischemic
injury (Danbolt, 2001, Scimemi et al., 2006). Collectively, these findings highlight
the importance of proper glutamate regulation for normal hippocampal function.
Much of our present understanding about the neurotransmitter role of
glutamate comes from electrophysiological investigations conducted in ex vivo
tissue such as hippocampal slices, isolated nerve terminals and cell cultures
(Nicholl et al., 1993; Hjelmstad et al., 1997; Takeda et al., 2007). Often, data
obtained from these studies is inconsistent, partly due to variations in the
experimental methodology followed by different research groups, but more likely
due to the inherent limitations of studying a brain region without its complete set
of intrinsic and extrinsic connections. More importantly, electrophysiology does
not allow for direct measurement of glutamate concentration. In vivo recordings
in the intact hippocampus using microdialysis probes have found some success
in measuring tonic glutamate concentration in whole tissues (Bagley and
Moghaddam, 1997; Clapp-Lilly et al., 1999) but this methodology also has
important limitations. Dynamic properties of glutamate neurotransmission cannot
be investigated in microdialysis recordings because the slow sampling rates of
this technique (minutes) cannot capture the rapid glutamate release and uptake
(milliseconds) events. Measurements of tonic glutamate alone are inadequate
because subtle changes in synaptic connectivity may be masked by homeostatic
compensation, an expected biological mechanism in most in vivo investigations.
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Microdialysis probes also cause extensive damage to surrounding brain
parenchyma (Clapp-Lilly et al., 1998) due to their large size (0.38 mm).
The size of the microdialysis probe also limits subregional investigations in
the hippocampus, which in rodents, is only a few millimeters wide (Paxinos and
Watson, 2005). Though the cytoarchitectonically distinct dentate gyrus (DG),
cornu ammonis 3 (CA3) and cornu ammonis 1 (CA1) fields of the hippocampus
operate in a concerted fashion in the normal brain, evaluation of glutamate
regulation in discrete subregions is needed because they are distinct with respect
to synaptic connectivity, surface distribution of glutamate receptors and mRNA
content (Gegelashvili et al., 1998; Wilson et al., 2005; Greene et al., 2008). In
addition to the observation that subregions demonstrate unequal susceptibility to
pathological insults (Amaral et al, 1971; Andersen et al., 2007), behavioral testing
implicates a different role for dorsal and ventral hippocampal regions with respect
to cognitive learning and memory encoding (Kesner and Hopkins, 2006). Since
information relay in the hippocampal trisynaptic pathway takes places through a
series of excitatory connections, we hypothesize that differential regulation of
glutamate neurotransmission within the DG, CA3 and CA1 fields contributes to
the observed regional differences in hippocampal function and disease
vulnerability. A scientific study of these potential differences, to our knowledge,
has not been conducted.
To address this need, we developed a novel MEA design (W4 MEA)
comprised of four Pt surfaces (20 X 150 μm) arranged in dorsal-ventral pairs
(shown in Figure 2.1 in Chapter Two). The total recording area of this design
(3000 µm2) is approximately 40% smaller than our standard MEA design, ideal
for targeted measurements in the cytoarchitectonic layers of the rat
hippocampus. In the present studies, W4 MEAs were configured for selective
glutamate detection and coupled with amperometry to obtain subsecond (2 Hz)
neurotransmitter recordings, similar to our previous studies in rodents and nonhuman primates (Burmeister et al., 2002, 2003, Nickell et al., 2006; Thomas et
al., 2009; Quintero et al., 2008). In vivo, the W4 MEA’s recording sites were

57

targeted to cell layers containing the dendrites of hippocampal principal neurons
in the each subregion, specifically the infrapyramidal molecular layer of the DG,
the stratum lucidum of CA3 field and the stratum radiatum of the CA1 field.
These locations correspond to synapses 1, 2 and 3 of the hippocampal
trisynaptic circuit, respectively. Accurate placement was achieved by stereotactic
placement in brain tissue and verified post-experimentally from MEA track
locations. First, resting (tonic) levels of extracellular glutamate were determined
in the DG, CA3 and CA1 subregions using a dual recording strategy that allowed
isolation of electrochemical signals corresponding to glutamate measurements
(Day et al., 2006; Thomas et al., 2008). Secondly, we investigated phasic
glutamate release from nerve terminals localized to the DG, CA3 and CA1 by
delivering either 70 mM or 120 mM potassium solution (KCl) through a
micropipette attached to the W4 MEA (Thomas et al., 2008). These experiments
were conducted to evaluate subregional capacities for KCl-evoked glutamate
release under different depolarizing conditions. The temporal properties of
stimulus-evoked glutamate release were evaluated from the rising portion of
glutamate signals. Subregional capacity for glutamate uptake was determined by
local applications of exogenous glutamate (100 µM) and subsequent evaluation
of signal decay. Finally, a depth profile of hippocampal glutamate levels was
obtained by measuring resting levels of glutamate and 70 mM KCl-evoked
glutamate release in the CA1 (stratum oriens and radiatum) and in DG
(suprapyramidal molecular layer, polymorphic layer and infrapyramidal molecular
layer).
The acute experiments conducted in this study are important because
they validated the capability of the W4 MEA to provide novel data about real-time
glutamate neurotransmission from discrete subregions of the hippocampus.
Future studies on subregional regulation of hippocampal glutamate will probably
be conducted in unanesthetized rats because these experiments offer the
potential to correlate regulation of glutamate neurotransmission with hippocampal
dependent learning. Additionally, glutamate measurements from unanesthetized
rats

may

provide

a

unique

perspective
58

on

alterations

in

excitatory

neurotransmission during hippocampal aging and disease that is not available
through conventional recording methodologies. To date, we have successfully
adapted the standard MEA design for chronic glutamate measurements in the
prefrontal cortex of freely moving rats and mice (Rutherford et al., 2007).
Therefore, a second goal of these studies was to evaluate the chronic recording
capability of W4 MEAs following implantation in the CA1 subregion of the rat
hippocampus.

3.2 Materials and Methods
Please refer to Chapter Two for a detailed description of animal care, MEA
preparation, recording methodology for in vitro and in vivo amperometry,
histology procedures, post-experimental data processing and statistical analysis.

3.3 Results (I): Glutamate Recordings in the Anesthetized Rat
Hippocampus
3.3.1 Resting Levels of Extracellular Glutamate in the Hippocampal
Trisynaptic Circuit
Our MEA technology utilizes a dual recording strategy to allow subsecond
(2 Hz) resting or tonic measurements of extracellular glutamate. This temporal
resolution, along with the W4 MEA’s capability to target discrete cytoarchitectonic
layers within subregions of the rat hippocampus is an important advancement
over previous MEA designs and is unparalleled in current scientific literature. In
the present studies, resting glutamate was reliably measured in discrete
hippocampal subregions in F344 rats, specifically the infrapyramidal molecular
layer of the DG, the stratum lucidum of CA3 field and the stratum radiatum of the
CA1 field. Average resting glutamate levels are seen in Figure 3.1: DG (2.9 µM ±
0.4, n = 15); CA3 (3.3 µM ± 0.6, n=15); CA1 (2.6 µM ± 0.3, n = 16). These data
indicate that resting glutamate is not significantly different {F(2, 43) = 0.3, p = 0.7}
across the trisynaptic circuit in urethane-anesthetized rats.
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3.3.2 KCl-evoked Glutamate Release in the Rat Hippocampus
Application of nanoliter volumes (12.5 – 50.0 nL) of 70 mM or 120 mM KCl
(isotonic, pH 7.4) resulted in stimulation of the extracellular environment adjacent
to the MEA. This allowed us to investigate glutamate release from nerve
terminals in the discrete DG, CA3 and CA1 subregions of the rat hippocampus.
Repeated ejections of 70 mM KCl (lasting 0.5 s) in the DG, CA3 and CA1
resulted in robust volume-dependent increases in glutamate signal amplitude (4 80 μM) relative to baseline concentration (Figure 3.2 A). In each region,
glutamate signals were transient (5 – 12 s) and reproducible (every 60 seconds).
Figure 3.2 B shows average glutamate signal amplitudes in the DG (17.5 µM ±
3.9), CA3 (7.4 µM ± 0.4) and CA1 (16.0 µM ± 1.1) (n = 7 per region). Thus, KClevoked glutamate signals were significantly smaller in the CA3 field (p < 0.05,
F(2, 18) = 6.6) compared to the DG and CA1 subregions of the rat hippocampus.
The variances of these data were significantly different with Bartlett’s test p <
0.0001.
Local application of 120 mM KCl in the DG, CA3 and CA1 hippocampal
fields revealed further differences in subregional glutamate release capacity.
Figure 3.3 A, B shows representative signals and average glutamate signal
amplitudes for the DG (6.9 µM ± 1.4), CA3 (3.3 µM ± 1.4) and CA1 (17.7 µM ±
1.2) (n = 6 per region). Glutamate release was reproducible in the CA1 field and
glutamate signals measured in this subregion were the largest in the
anesthetized rat hippocampus. As before, glutamate signals were significantly
smaller in the CA3 (p < 0.001, F (2, 11) = 29.8). However, in approximately 50%
cases, we observed a complete suppression of glutamate release in the CA3
after repeated application 120 mM KCl ejections. This effect lasted for more than
90 minutes and was also observed in the contralateral CA3 field.
Interestingly, glutamate release was significantly diminished in the DG (p <
0.001, F (2, 11) = 29.8). Diminished capacity for glutamate release was also
significant relative to 70 KCl evoked stimulation (t(7) = 2.9, p = 0.02, F-test p =
0.44) (Figure 3.4). Collectively, these data suggest that terminal glutamate
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release is dependent upon KCl concentration and is regulated differently in
subregions of the rat hippocampus.
3.3.3 Rise Time of Glutamate Signals following KCl Stimulation in
Hippocampal Subregions
Because the time taken to reach maximum signal amplitude, or rise time
(TRISE), is an important temporal indicator of glutamate neurotransmission, KClevoked glutamate signals from each subregion were evaluated with respect to
this kinetic parameter. In these analyses, glutamate signals resulting from 120
mM KCl stimulation in the CA3 were excluded because a majority of the signal
amplitudes did not satisfy the defined signal selection criteria (signal amplitudes
in the range 8-15 µM).
Figure 3.5 (inset) shows average TRISE in the DG (1.7 s ± 0.2), CA3 (2.0 s
± 0.4) and CA1 (1.7 µM ± 0.2) (n = 6 per group) hippocampal subregions
following 70 mM KCl stimulation, and in DG (1.1 s ± 0.1) and CA1 (1.3 s ± 0.2)
subregions following 120 mM KCl stimulation. Comparison across subregions
and between treatment groups revealed that TRISE was significantly smaller
(p<0.05) in the DG following stimulation with 120 mM KCl (t(6) = 2.63, p = 0.04).
This result is illustrated in Figure 3.5 by superimposing representative glutamate
signals from DG recordings. It is important to note that differences (or lack
thereof) in TRISE were not caused by variability in experimental factors such as
the distance of the micropipette from the MEA or the relative position of the
micropipette tip from the recording sites. Together with the evoked-release data,
these results show that the temporal properties of glutamate release in the CA1
and CA3 fields are unaffected by KCl concentration; however, in the DG
subregion, diminished glutamate release following at high KCl concentration is
accompanied by faster glutamate signaling.
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3.3.4 Glutamate Clearance Capacity in Subregions of the Rat Hippocampus
Evaluation of the robust decay of glutamate signals is an important goal of
these studies because it is indicative of glutamate transporter activity. Glutamate
release and clearance are dynamic, overlapping processes. Therefore, it is not
possible to completely isolate the clearance phase from KCl-evoked glutamate
signals. In addition, KCl stimulation is non-specific, resulting in the co-release of
several modulatory neurochemicals in addition to glutamate. These limitations
were avoided by locally applying an exogenous glutamate solution (100μM in
0.9% saline, pH 7.4) into the DG, CA3, and CA1 discrete hippocampal regions.
Also, electrogenic glutamate transporters are known to behave in accordance
with first order Michaelis-Menten kinetics. Therefore, subregional capacities for
physiological glutamate release were mimicked by applying solution volumes in
the range 25-150 nL. Statistical comparisons were made on amplitude-matched
data (6-15 μM) to ensure that variations in glutamate signal amplitude would not
contribute to changes in uptake rate. Average rates of glutamate uptake were not
significantly different {F(2,17) = 0.68, p = 0.52} between the DG (1.8∙sµM
0.6), CA3 (1.1 µM
∙s

-1

± 0.3) and CA1 (1.7 µM
∙s

-1

-1

±

± 0.5) (n = 6 per group)

regions, though a trend for slower uptake was observed in the CA3 field (Figure
3.6). These data indicate that the activity of glial and neuronal excitatory amino
acid transporters is comparable in hippocampal subregions in anesthetized F344
rats.
3.3.5 Depth Profile of Resting Glutamate and Stimulus-evoked Glutamate
Release in the Rat Hippocampus
The final experiments of the present study involved depth measurements
of hippocampal resting glutamate in the stratum oriens and radiatum of the CA1
field and the suprapyramidal molecular, polymorphic and infrapyramidal
molecular layers of the DG. As shown in Figure 3.7, average resting glutamate
levels were not significantly different between discrete cell layers in urethane
anesthetized rats. {F(4,17) = 0.3, p = 0.8, n = 3}.
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Lastly, Figure 3.8 shows average glutamate signal amplitudes obtained at
each depth following repeated injections of 70 mM KCl (25 nL). Glutamate
release capacity was significantly larger in the stratum radiatum (12.7 µM ± 0.3)
than the stratum oriens (5.2 µM ± 0.5, p<0.0001) of the CA1 field (Figure 3.3).
Similarly, the infrapyramidal molecular layer of the DG had the largest signals
(13.5 µM ± 0.8) compared to the suprapyramidal molecular layer (7.2 µM ± 0.6)
and the polymorphic cell layer (6.3 µM ± 0.6), {F(4,17)=45.55; n = 3 per group}.
Thus, the rat hippocampus demonstrates depth-related differences in glutamate
release capacities that are significant both within and between subregions.

3.4 Discussion: Studies of Glutamate in the Anesthetized Rat Hippocampus
In this study, we have shown that tonic glutamate levels in the discrete
DG, CA3 and CA1 subregions of the hippocampus are not significantly different
in anesthetized F344 rats.

However, the trisynaptic pathway does exhibit

stimulus-dependent changes in KCl-evoked glutamate release in specific
subregions. Of the three subregions, stimulus-evoked release of glutamate with
70 or 120 mM KCl was significantly greater from terminals localized to the CA1
field. In contrast, glutamate release was significantly lower in the CA3 subregion.
These data suggest that less glutamate was found in the extracellular space
around the MEA in the CA3 region. The most fascinating findings in this study
were from KCl studies in the DG subregion. KCl-evoked glutamate release
capacity in DG terminals was significantly diminished following high K+
stimulation but demonstrated faster release kinetics, providing evidence for
modulation of presynaptic glutamate release from local nerve terminals.
Clearance of exogenous glutamate was not significantly different in the DG, CA3
or CA1 subregions, suggesting similar capabilities for glutamate clearance in the
trisynaptic circuit. Finally, depth profile investigations of hippocampal layers in the
CA1 and DG demonstrated cell layer-specific differences in evoked glutamate
release capacity, as seen with local application of 70 mM KCl. Collectively, these
findings validate the capability of the W4 MEA to target discrete cell layers of the

63

rat hippocampus and provide direct evidence for subregion specific regulation of
glutamate neurotransmission in the anesthetized rat hippocampus.
3.4.1 Resting Levels of Extracellular Glutamate are Similar throughout the
Hippocampal Trisynaptic Circuit in Anesthetized Rats
Previous studies report resting levels of hippocampal glutamate between 1
and 5 µm (Miele et al., 1996; Zhang et al., 2004), obtained by in vivo
microdialysis measurements. However, due to the relatively large size of
microdialysis probes, current scientific literature is lacking in resting glutamate
data for individual subregions of the hippocampus. The present studies used a
novel MEA design to obtain resting glutamate measurements from discrete
regions of the adult rat hippocampus and showed that extracellular glutamate
was not significantly different in the DG, CA3 and CA1 subregions. Averaged
across the three subregions, our resting glutamate levels are comparable with
previous microdialysis data. However, recent studies from our laboratory suggest
that urethane anesthesia can alter basal glutamate in the prefrontal cortex
(Rutherford et al., 2007). Further investigations in unanesthetized rats are
needed to address this issue.
3.4.2 Capacity for Stimulus-evoked Glutamate Release is Different in
Hippocampal Subregions
Since the temporal resolution of our MEA technology is an order of a
magnitude faster (0.5 s) than the most advanced microdialysis technique (6s)
(Kennedy et al, 2002, Rossell et al., 2003), the W4-MEA can measure
extrasynaptic spillover of endogenous glutamate from depolarized nerve
terminals following KCl stimulation. The experiments described in this study
validated this recording capability and also showed that the W4-MEA can detect
micromolar differences in KCl-evoked release of glutamate in discrete
hippocampal subregions.

64

We showed that stimulation with 120 mM KCl (but not 70 mM KCl)
resulted in decreased glutamate release capacity in the DG subregion. Only one
previous study has directly measured glutamate release in the DG region of the
rat hippocampus with KCl stimulation (Hu et al., 1994). Their study showed that
stimulus-evoked glutamate signals were reproducible in the DG provided a rest
period of 20 minutes was allowed between consecutive applications (~1000 nL)
of 100 mM KCl solution. Yu and colleagues reasoned that this refractory period
was caused by depletion of vesicular glutamate stores in presynaptic nerve
terminals. The present study does not support this rationale because glutamate
signals can be produced every 60 seconds with 70 mM KCl stimulation.
Interestingly, high frequency electrical stimulation of DG tissue for short periods
of time (seconds to minutes) has been shown to cause reversible inactivation of
afferent glutamatergic fibers (Kwon and Castillo, 2003). It is possible that
excessive stimulation with high concentration KCl solution produce a similar
effect in our studies. If so, our finding that attenuation of terminal glutamate
release in the DG subregion takes place after repeated depolarization with high
K+ levels supports a role for presynaptic modulatory mechanisms. This is a
fascinating finding because activation of presynaptic mGluRs (group II and III) in
the DG has been shown to inhibit long term potentiation (LTP) and facilitate short
term depression (STD) in hippocampal tissue slices (Kew et al., 2000,
Klausnitzer, Kulla and Manahan-Vaughan, 2003). Blockade of the same
autoreceptors adversely affects long term depression (LTD) (Kilbride et al., 1998,
2001). LTP and LTD have been extensively studied by electrophysiologists
because long lasting changes in synaptic strength are believed to be critical for
hippocampal-dependent learning (for review on Morris et al., 2003; Lynch, 2004)
and proposed to be functional equivalents of memory formation (Andersen et al.,
2007). Moreover, impaired cognition is an area of intense interest in studies of
aging (Gallagher and Nicolle, 1993, Nagahara et al., 2008) and age-related onset
of Alzheimer’s disease (Ackl et al., 2005; Lupien et al., 2009). For future
investigations, an experimental paradigm that combines real-time glutamate
measurements with our MEAs and pharmacological manipulation of presynaptic
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mGluRs offers the greatest potential for understanding regulation of glutamate
neurotransmission in DG function.
The present experiments also showed that glutamate release in the CA3
subregion was significantly lesser than the DG and CA1 hippocampal fields. To
our knowledge, direct in vivo investigations of glutamate release capacity have
not been conducted in the CA3, or for that matter, in any CA field. Diminished
release capacity of nerve terminals targeting the CA3 region is an important
finding because it suggests that glutamate is modulation differently in this
subregion. The most straight-forward explanation for this result could be that less
glutamate is released from nerve terminals projecting to the CA3 field. This
suggests that less glutamate is available for post-synaptic receptor activation and
downstream cell signaling, either due to leading to decreased innervation of postsynaptic targets throughout the hippocampus. Prior work on presynaptic
glutamate content in hippocampal subregions does not support this line of
reasoning though actual vesicular release probability has not been directly
investigated.
Increased activity or numbers of neuronal and glial glutamate transporters
can be argued to affect the amount of glutamate that escapes the extrasynaptic
cleft and reaches the recording sites of our MEA. Indeed, EAAC1 is selectively
enriched in the CA3 subregion (Rothstein et al., 1994). However, the present
study showed that rate of glutamate uptake is not significantly different between
subregions and does not support this explanation. Instead, we suggest that the
anatomy of CA3 synapses may provide insight about the observed results of this
study. Mossy fiber terminals synapsing onto the thorny excrescences of CA3
pyramidal neurons are the most unique axonal fibers in the brain because they
are large in size and are known to enclose their post-synaptic targets (Danbolt,
2001). In addition, it has been proposed that glutamate molecules release from
mossy fiber terminals must travel a greater distance to escape the synaptic cleft
(Andersen et al., 2007). The total amount of extracellular space has also been
shown to decrease with aging in the CA3 (Segovia et al., 2001). Since glutamate
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transporters are extensively distributed on synaptic and extrsynaptic membranes,
it is conceivable that the probability for glutamate molecules to spill-over into the
extracellular space is lower in the CA3 subregion. A role for presynaptic
modulation of glutamate release by mGluRs, KARs and GABAR autoreceptors
has also been proposed for CA3 terminals (Moulder and Mennerick, 2006).
Finally, the attenuation of glutamate release following high K+ stimulation
may represent homeostatic control of glutamate signaling through decreased
cellular intake of calcium (Martinez-Serrano et al., 1996; Piedras- Renteria et al.,
2004) or by direct modulation of exocytotic machinery (Kew et al., 2000). In these
context, KCl volume-dependent increase in the CA1 field is particularly
interesting because it is indicates the glutamate neurotransmission is modulated
differently in this subregion. As mentioned previously, each hippocampal
subregion receives excitatory inputs from multiple serial and parallel pathways.
The present study did not discriminate between sources of terminal glutamate.
Therfore, future studies involving selective lesioning of presynaptic inputs or
pharmacological inactivation of pre-terminal axons may be useful for identifying
the

contribution

of

individual

pathways

to

subregional

glutamate

neurotransmission.
3.4.3 Stimulus-evoked Glutamate Release is Faster in the DG Subregion
Stimulation with high concentration KCl solution caused faster release of
glutamate in the DG compared to other hippocampal subregions. To our
knowledge, altered release kinetics ha

ve

not

been

investigated

for

hippocampal glutamatergic terminals. Exocytotic release has been investigated
in cerebellar granule cells (Holopainen and Kontro, 1987) and hippocampal
gabaergic neurons (Edwards et al., 1990). A number of investigations have also
been conducted through computational modeling (Vautrin et al., 2003).
Collectively, these studies suggest that autoreceptors (both neurotransmitter and
peptide activated) can cause changes in proteins and mRNA participating in the
exocytotic machinery through a Calcium-mediate process. Specifically, an
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increase in neurotransmitter release may be the result of incomplete vesicular
fusion with the terminal cell membrane (Sudhof et al., 2003). A similar process
may be taking place in DG terminals because we observed that faster release
was accompanied by an overall decrease in glutamate signal amplitude. High
levels of extracellular K+ have also been shown to cause reversal of glial
glutamate

transporters

(Szerb,

1990).

Additional

investigations

using

pharmacological agents are needed to determine the source and mechanism of
faster glutamate signals.
3.4.4 Rate of Glutamate Uptake is not Significantly Different in the
Trisynaptic Circuit of Anesthetized rats
Finally, the W4 MEA was able to measure the temporal properties
subsecond changes in extracellular glutamate concentration. Using this
capability, we showed that glutamate uptake was rapid but not significantly
different in the hippocampal trisynaptic circuit of anesthetized F344 rats. These
data emphasize the importance of tight glutamate regulation in maintaining
targeted activation of synaptic targets. Since loss of glutamate regulation can be
caused either by uncontrolled release or compromised uptake, selective
blockade of transporters using pharmacological agents offer the potential to
understand compensatory regulatory mechanisms in discrete hippocampal
subregions.

3.5 Results (II): Glutamate Recordings in the Unanesthetized Rat
Hippocampus
3.5.1 Verification of Glutamate Signals in the CA1 Subregion of the
Unanesthetized Rat Hippocampus
Our modified W4-MEA was coupled with the FAST16mkII instrument for
subsecond amperometric recordings of extracellular glutamate in the F344 rat
hippocampus on days 4, 5 and 6 following surgical implantation. On each day,
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local application of 1 mM glutamate solution (2.5 – 5 µl, pH = 7.4, prepared in
0.9% saline) through the internal cannula was used to confirm MEA recording
capability for glutamate. As shown in Figure 3.9, our dual recording strategy
allowed for visualization of current from enzymatic breakdown of exogenous
glutamate on the glutamate oxidase-coated sites. Also, local application of saline
solution as a control did not produce changes in baseline glutamate
concentration.
3.5.2 Resting Levels of Extracellular Glutamate in the CA1 Subregion of the
Unanesthetized Rat Hippocampus
Following a recovery period of 3 days, resting levels of extracellular glutamate
were measured on days 4, 5 and 6 from the CA1 field of unanesthetized F344
rats. These measurements were conducted to evaluate the recording
performance of chronic MEAs in the hippocampus. Figure 3.10 shows that
resting glutamate was not statistically different in the CA1 on day 4: 13.8 µm ±
1.7, day 5: 16.6 µm ± 1.9, and day 6: 17.9 µm ±1.6; F(2, 7) = 1.215; n = 3.

3.6 Summary of Glutamate Studies in the Unanesthetized Rat Hippocampus
We showed that the chronic W4-MEA is capable of reliably measuring
glutamate at subsecond rates (2Hz) in the CA1 subregion of the unanesthetized
rat hippocampus. Resting levels of extracellular glutamate were measured on
days 4, 5 and 6 and were not significantly different over days. Studies using
additional animals along with glutamate recordings from the CA3 and DG
hippocampal subregions are needed to compare resting glutamate levels
measured by our MEA technology with existing microdialysis data. However, the
present results are consistent with our previous published studies using S2MEAs in the PFC and striatum of Long Evans rats (Rutherford et al., 2007) and
C57BL6 mice (Hascup et al., 2007). Our ability to measure exogenous glutamate
from day 4 to day 6 and the consistent resting levels seen on all three days
suggest that the enzyme coating on the Pt sites is functional for at least 6 days in
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the rat hippocampus. W4-MEA viability was not evaluated beyond 6 days in the
present study. However, we have previously shown that our chronic S2-MEAs
are responsive to exogenous hydrogen peroxide applications for up to 90 days
(Rutherford et al., 2007). Additional investigations are needed to evaluate the
properties of the enzyme layer and the overall recording longevity of our MEAs.
However, the present studies indicate that our W4-MEAs are capable of
measuring hippocampal glutamate over multiple days and can be combined with
behavioral experiments for future investigations in unanesthetized rats.
Copyright © Pooja Mahendra Talauliker 2010
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Figure 3.1: Average extracellular levels of resting glutamate in subregions
of the hippocampal trisynaptic circuit. Extracellular levels of resting glutamate
were not significantly different in the DG: 2.9 µM ± 0.4, n=15, CA3: 3.3 µM ± 0.6,
n=15 and CA1: 2.6 µM ± 0.3, n=16; F (2, 43) = 0.33, p = 0.7.
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A

B

Figure 3.2: Comparison of glutamate release capacity in subregions of the
rat hippocampus following stimulation with 70 mM KCl. Panels A and
Bshows that application of KCl solution (70 mM, isotonic, pH 7.4, 12.5 - 50 nL)
revealed differences in glutamate release in hippocampal subregions. Average
maximum signal amplitudes are shown: {DG: 17.5 µM ± 3.9; CA3: 7.4 µM ± 0.4;
CA1: 16.0 µM ± 1.13 µM; n = 7; F(2, 18) = 6.6, p = 0.0071}. The variances of
these data were significantly different with Bartlett’s test p < 0.0001. These data
show that glutamate release was significantly diminished in the CA3 subregion
compared to the CA1 and DG (*: p < 0.05).
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A

B

Figure 3.3: Comparison of glutamate release capacity in subregions of the
rat hippocampus following stimulation with 120 mM KCl. Panels A and B
show that application of 120 mM KCl solution revealed additional differences in
subregional glutamate release capabilities. Specifically, glutamate release was
significantly diminished in the DG and CA3. {DG: 6.9 µM ± 1.4; CA3: 3.3 µM ±
1.4; CA1: 17.7 µM ± 1.2; n=6; F (2, 11) = 29.8}. Significance was defined as ***:
p < 0.001
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Figure

3.4:

KCl

concentration-dependent

alteration

in

subregional

glutamate release capacity. Between treatment groups, the DG region showed
pronounced loss in signal amplitude {t(7) = 2.89, p = 0.023, F-test p=0.44 while
the CA3, showed a moderate decline {t(2)=2.824, p=0.11}.
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Figure 3.5: Rise times to maximum signal amplitude following local
application of 70 or 120 mM KCl in the DG subregion. Comparison of rise
times in each region showed significantly faster glutamate release in the DG with
120 mM KCl application {t(6) = 2.63, p = 0.04}.
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Figure 3.6: Average rates of glutamate uptake in the hippocampal
trisynaptic pathway. Local application of 100 µM glutamate solution showed
that clearance of glutamate was not significantly different {F(2,17)=0.68, p=0.52}
in the DG (1.78µM ± 0.55µM), CA3 (1.06µM ± 0.28µM) and CA1 (1.70µM ±
0.47µM) regions of the anesthetized rat hippocampus.
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Dorsal

Ventral

Figure 3.7: Depth profile of resting glutamate in the anesthetized rat
hippocampus. Resting levels of extracellular glutamate were obtained at 5
depths, each separated by 0.35 mm. As measured from the surface of the brain,
the depths corresponded to the stratum oriens and stratum radiatum of the CA1
and the suprapyramidal molecular layer, polymorphic layer and infrapyramidal
molecular layer of the DG. Average resting glutamate was not significantly
different between regions {F(4,17) = 0.3, p = 0.8, n = 3}.
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Dorsal

Ventral

Figure 3.8: Depth profile of KCl-evoked glutamate in the anesthetized rat
hippocampus. Hippocampal glutamate release capacity following stimulation
with KCl solution was investigated at 5 different depths, each separated by 0.35
mm. Average glutamate signal amplitude was significantly larger in the stratum
radiatum (12.7 µM ± 0.3) than the stratum oriens (5.2 µM ± 0.5, p<0.0001)of the
CA1 field. Similarly, the infrapyramidal molecular layer of the DG had the largest
signals (13.5 µM ± 0.8) compared to the suprapyramidal molecular layer (7.2 µM
± 0.6) and the polymorphic cell layer (6.3 µM ± 0.6), {F(4,17)=45.55; n = 3 per
group}.
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Figure 3.9 Validation of glutamate signals in the CA1 subregion of the
unanesthetized rat hippocampus. Local applications of 1 mM glutamate
solution (2.5 – 5 µl, pH = 7.4, prepared in 0.9% saline) were used to confirm MEA
recording capability for glutamate. Our dual recording strategy allowed for
visualization of current from enzymatic breakdown of exogenous glutamate on
the glutamate oxidase-coated sites (blue).
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Figure 3.10: Resting glutamate measurements over three days in the CA1
subregion of unanesthetized rats. Following a recovery period of 3 days,
resting levels of extracellular glutamate were measured on days 4, 5 and 6 in the
CA1 field of F344 rats. Resting glutamate was not statistically different in the CA1
up to 6 days post-surgery. Day 4: 13.8 µm ± 1.7, Day 5: 16.6 µm ± 1.9, Day 6:
17.9 µm ±1.6; F(2, 7) = 1.215; n = 3.
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Chapter Four: Surface Characterization and Topographical Analysis of
MEAs

4.1 Introduction
Detailed surface characterization is a necessary first step towards
improving the performance of MEAs intended for in vivo electrochemical
recordings. Under acute experimental conditions, high quality signal generation is
dependent upon electrode sensitivity and selectivity for the analyte of interest
(Reiner et al., 2006), total electroactive area and reaction kinetics (Ozden et al.,
1998). To improve these recording parameters, knowledge about intrinsic
physical and electrochemical properties of the recording surface such as
topography, electrical behavior, chemical reactivity and molecular composition is
necessary.
In chapter three, we used novel ceramic-based MEAs with oxidase
enzyme-coated recording sites to measure resting levels of extracellular
glutamate in the hippocampus of unanesthetized rats. Glutamate measurements
could be obtained up to 6 days post-surgery, but high levels of background noise
restricted extended neurotransmitter measurements, indicating a change either in
the extracellular environment or the enzyme layer, perhaps both. Until now, the
microscale topography of the MEA, which is predominantly composed of ceramic
alumina (Al2O3), has never been studied. Traditionally, ceramic has been the
material of choice for orthopedic prostheses and dental implants because of its
structural strength and negligible tissue reactivity (Hulbert, 1972; Williams et al.,
1989). In these devices, improved rates of implant success have been achieved
primarily by altering the roughness of the ceramic surface.

For example,

replacement hip joint prostheses show enhanced integration with host tissue
when the roughness value of the implant surface is equivalent to the dimensions
of bone-forming cells (50 - 400 µm). Increased roughness is also useful for
improving the anchorage of dental implants but can compromise oral health by
promoting bacterial growth and plaque formation (Boyan 1996, Shackelford
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1999). Analogous studies on central nervous system biocompatibility are lacking
because the utilization of ceramic-based neural devices as a tool for chronic
investigations is a very recent development (Rutherford et al., 2007; Hascup et
al., 2008). We have begun to examine the tissue effects of our MEAs in
implanted rats (Rutherford et al., 2007, Hascup et al., 2009); however, the
surface topography of the MEAprior to implantation also needs to be studied.
Platinum is widely used in amperometric electrodes, both planar and wirebased, because of its lasting biocompatibility and high catalytic activity for
amperometric

measurements

of

hydrogen

peroxide.

In

a

majority

of

electrochemical experiments utilizing platinum-based electrodes, hydrogen
peroxide is generated as a reporter molecule following the enzymatic oxidation of
the molecule of interest. It is generally held that the reaction mechanism of
hydrogen peroxide oxidation on platinum surfaces is independent of electrode
geometry (Hall et al., 1998; 1999). However, a review of current scientific
literature reveals that this similarity does not translate to equivalent recording
performance per unit area (Table 4.1). Dissimilarities in analyte sensitivity and
recording lifespan observed both within and between electrode types can be
hypothesized to have been caused by differences in material selection and
fabrication processes but, to our knowledge, are yet to be directly investigated.
In the present chapter, we studied the surface characteristics of our
microelectrodes

using

complementary

investigative

techniques.

In

vitro

calibration was conducted to compare the performance of S2 and W4 MEAs.
Scanning electron microscopy (SEM) was utilized to obtain high resolution
secondary electron micrographs of MEA samples, allowing examination of submicron sized topographical features. Further, backscattered electron microscopy
(BSE) and energy dispersive spectroscopy (EDS) were used to visualize surface
composition, and to detect potential contaminants on the recording sites. The
qualitative information gained from these experiments was supplemented by
topographical analysis and roughness estimation using atomic force microscopy
(AFM). As a whole, these studies are the first to describe the surface properties
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of an implantable ceramic-based neural device. The present results will also be
useful to ongoing efforts aimed at improving and extending the recording
performance of our MEAs.

4.2 Materials and Methods
Please refer to Chapter Two for a detailed description of MEA fabrication,
surface cleaning methods, sample preparation and imaging procedures for
scanning electron microscopy and atomic force microscopy.

4.3 Results and Discussion
4.3.1 In Vitro Performance of W4 and S2 MEAs
We compared the in vitro performance of W4 and S2 MEAs through
beaker calibrations. As shown in Figure 4.1 A, the average sensitivity (slope) of
W4 MEAs (-5.7 x 10-3 nA∙µM-1 ± 6.8 x 10 -4, n = 14) was not significantly different
from S2 MEAs (-7.5 x 10-3 nA∙µM-1 ± 1.3 x 10-4, n = 10). However, the average
limit of detection (LOD) was significantly higher for W4 MEAs (0.61 µM ± 0.08, n
= 14) when compared to S2 MEAs (0.24 µM ± 0.04, n = 10). **: (p < 0.0.1)
(Figure 4.1 B). The higher LOD is likely due to the lower surface area of Pt sites
on W4 MEAs. A smaller site leads to less signal being obtained per unit surface
area. Since the RMS noise on the signal is unchanged between MEA designs,
the signal to noise ratio is lower for the W4 MEA and by definition results in a
higher LOD. At the same time, we note that the average LOD values for W4
MEAs are well within≤ 1 µM. Taking this result together with the comparable
sensitivities of both designs, we conclude that the W4 MEA meets our
performance criteria for in vivo experimentation.
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4.3.2 Photolithography Produces Recording Sites with Microwell Geometry
Images A and B (Figure 4.2) are secondary electron micrographs of the tip
of a W4 MEA. In this type of imaging, the signal source is provided by low energy
electrons that are released when the incident electron beam impacts the sample
surface. For these experiments, the MEA was rotated in the X-Y plane and tilted
with respect to the incident beam such that the images were maintained in focus
while maximizing the yield of textural information. The front face of the MEA is
comprised of an array of platinum sites and their connecting lines overlying a
machined ceramic base. Except for the working sites, the entire surface is
enclosed underneath a continuous layer of insulating polyimide (Figure 4.2 B,
rotation angle: 50°; tilt angle: -10°). Interestingly, the bare recording sites are
marked with irregular peaks and indentations, with approximate cross-sectional
areas in the range 0.04 – 25.06 µm2 (Figure 4.2, C and D, tilt angle = 0°).
Average layer thickness ranged between 0.1 - 0.3 µm for the recording sites and
1.0 - 2.5 µm for the polyimide film, measured manually using imaging software
(Axiovision, Zeiss Inc.). These numbers are consistent with manufacturer’s
specifications though some image distortion is expected because of sample
tilting. Thus, the photolithographic process produces recording sites with a
microwell geometry.
We have previously described the application of enzyme solutions and
interferent exclusion layers that readily bond to the recording surface in acute
experimental settings (Hascup et al., 2006; Thomas et al., 2008). Current
scientific research on protein attachment (or adsorption) to microwell structures is
largely focused on high throughput immunoassays and cell culture applications.
Comparison studies between micron-sized plates and wells demonstrated
superior protein immobilization in the latter design (Kang et al., 2005; Jung et al.,
2008). For chronic measurements (weeks to months), stable coating adhesion is
particularly important because the failure of the MEA implant is often associated
with decreased sensitivity and selectivity for the molecules of interest. While it is
plausible that the three dimensional geometry of the working sites aids in enzyme
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immobilization and contributes to extended neurochemical detection capability,
the evaluation of electrode sensitivity (in comparison to planar electrodes that
have inlaid or protruding geometry) is not straightforward. Additional parameters
such as the depth of the microwell, distance between electrodes on a multisite
array and software limitations must also be considered (Sandison et al., 2002).
Further investigation is needed to evaluate the long term adhesion properties of
coating solutions.
4.3.3 Ceramic Topography is composed of Micro/nanoscale Surface
Features
The reverse (opposite) face of the MEA is also machined but is free of
surface

coatings.

Here,

the

topography

is

dominated

by

intersecting

microgrooves (width < 1 µm) and irregular holes (cross-sectional area 0.1 – 10.0
µm2), both of which are believed to produced during the ceramic polishing
process (Figure 4.3, A and B). A detailed discussion on wear-related
microgroove and pit formation is beyond the scope of this chapter (see Zarudi
and Zhang, 1998; Ravikiran, 1999, 2000, 2000b for review). The topography of
the arrays is analyzed further in following sections. In contrast, the sides of the
microelectrode are composed of an extensive network of interconnected peaks
and pores, resulting in an extremely rough appearance (Figure 4.3 C). The
boundary region of a given peak was not readily distinguishable from adjacent
peaks or pores. Indeed, a base surface was not at all discernible; therefore
identification and cross-sectional measurements of individual surface features
could not be conducted. Larger surface cavities were composed of clusters of
smaller microfeatures and connected to other cavities or holes through fissures
and surface corrugations (red contouring shown in Figure 4.3 D, 0° tilt). Also,
note the increased brightness along the border of some structures in the image.
This edge effect is caused by sharp changes in the height/depth of sample
resulting in increased electron scattering in this region.
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4.3.4 Fabrication Errors and Defects from Photolithographic Processing
The occurrence of surface defects on approximately 5% of the
microelectrodes used in this study was an unexpected finding. The selected
examples shown in Figure 4.4 (A-D) suggest that these imperfections are the
result of fabrication errors during photolithography. For example, the active
surface area of a recording site is reduced when an offset in the photomask
displaces the boundaries of the polyimide layer (Figure 4.4 D). Similarly, a
disrupted polyimide coating may not provide an adequate shield for connecting
lines in an aqueous environment (Figure 4.4 C). We also observed defects in the
platinum circuitry. Electron micrographs A and B in Figure 4.4 illustrate
delamination of the platinum/titanium composite from the recording sites and
connecting lines. Though further investigations on defective MEAs were not
conducted, these findings emphasize the importance of quality testing
procedures. In particular, periodic surface examination of random microelectrode
samples may be useful for identifying a range of manufacturing errors that
compromise recording performance but may not be apparent to the naked eye.
4.3.5 Backscattered Electron Imaging (BSE) and Energy Dispersive
Spectroscopy (EDS)
Electron micrographs obtained by BSE detection clearly distinguished
between the ceramic substrate and the polyimide layer on the front surface of the
microelectrode (Figure 4.5 A). In these images, the intensity of the polyimide was
uniform, indicative of homogenous surface composition. Also, maximum image
intensity was produced by the platinum working sites, consistent with the working
principle of BSE imaging. Note that the resolution of BSE images is lower than
SE images (Figure 4.5 B) because backscattered electrons interact with a larger
volume of the sample leading to a loss in spatial resolution.
Because information about the elemental identity of a recording surface
can be useful for detecting potential contaminants and for evaluating
electrochemical behavior, we carried out EDS studies to analyze the elemental
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composition of the recording sites (Figure 4.6). Spectral analysis confirmed that
the recording sites are primarily composed of platinum. The multiple platinum
peaks on the graph are associated with excitation energy levels of different
electron orbitals. Apart from platinum, x-ray emissions corresponding to carbon
and silver were also detected and may have been transferred during the
photolithographic process. Carbon is known to impede amperometric detection of
hydrogen peroxide, therefore thorough cleaning of the recording surface is a
critical step in experimental preparation. If carbon is embedded into the recording
layers, it indicates a problem with the fabrication process. Accordingly,
quantification of total contaminant must be performed to determine whether it is
within the tolerance range of the device.
It is important to note that BSE and EDS techniques do not provide direct
information about the oxidation state of any element, though oxygen atoms can
be detected by the Silicon/Lithium Detector used in these studies. In this context,
the absence of oxygen in the atomic spectrum is a fascinating finding because
platinum naturally adsorbs oxygen molecules into its crystalline lattice. These
results also suggest that platinum may be present in its elemental state. The
leading hypothesis on platinum-based amperometric detection contends that the
reduction of hydrogen peroxide by platinum electrodes is actually the result of a
catalytic reaction with a thin layer of platinum oxide (Lingane and Anson, 1960).
Indeed, it is believed that the current detected at the electrode surface
corresponds to the re-oxidation of platinum to platinum oxide following hydrogen
peroxide reduction. Clearly, additional investigations are needed to determine
whether amperometric detection of hydrogen peroxide by our microelectrodes is
governed by a previously undetected electrochemical step or perhaps, involves a
different reaction altogether.
4.3.6 Platinum Sites are composed of Nanoscale Topographical Features
In a scanning electron micrograph, the scattering intensities of secondary
or backscattered electrons displaced from the sample surface are represented in
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gray scale. Despite the large depth of field, the image does not contain
information about surface height. To address this limitation, atomic force
microscopy was utilized to characterize the three dimensional topography of our
MEAs. Figures 4.7 A and B depict the typical micro and nanoscale topography
data of a recording site over 15×15 µm and 1×1 µm regions, respectively. The
spatial resolution of these diagrams is identical because the same AFM probe
was used to acquire topographical information. However, adjusting the sampling
area is useful for visualizing surface details at different magnification levels and
for isolating regions of interest. Variations in surface height are shown in the form
of a color gradient where lighter shading is indicative of regions with raised
topography while darker areas correspond to indentations or cavities. For the
present study, sample regions on the recording sites were selected randomly:
15×15 µm (NSITES = 3, NSAMPLES per site = 3, Height scale = 0 - 150 nm) and 1×1
µm (NSITES = 3, NSAMPLES per site = 3, Height scale = 0 - 20 nm). These data
supported the SEM study and verified non-uniform morphology of the platinum
sites. The actual shape and distribution of peaks and holes was visualized by
constructing three dimensional digital projections of the mapped data (Figure 4.8
A, B).
AFM data from these experiments was quantified to evaluate differences
in surface roughness between sites (Table 4.2). It is important to note that data
points beyond the site boundary were excluded to avoid artificial skewing of
results. Values for RAVG (arithmetic average of absolute values of peaks and
valleys within the selected area) and RRMS (root mean squared roughness)
obtained from 15 µm2 samples describe a surface with nanoscale roughness.
Roughness factors obtained from 1 µm2 images show greater variability because
they represent a small portion of the overall site. The RSKEW (dimensionless
number signifying the relative proportion of peaks and valleys) relays two
important pieces of information. Positive RSKEW indicates an asymmetric surface
with more peaks and holes. Additionally, values >1 suggest the presence of
extreme peaks and holes and is verified by the average HMAX (maximum peak
height) and DMAX (maximum valley depth given in terms of absolute distance).
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Roughness analysis has some limitations. Calculations for RAVG and RRMS
do not include holes. Also, these values can be distorted by outlier peaks of
extreme height (for example, features in the height range of HMAX) and cannot tell
us whether features of a certain size occur more frequently than others (mode or
median value). Finally, RSKEW does not account for the actual distribution of
peaks and holes so the roughness value for two sites can be identical even if the
peaks are grouped together on one site but are distributed evenly on the other. A
typical scenario is illustrated in Figure 4.9 (20×20 µm scan area).
To address this, we examined surface height across multiple crosssections of each site (representative image shown in Figure 4.10 A), also known
as line scan analysis. Overall, line profiles for each site indicate that the
topography of the sample recording sites is dominated by nanometer sized peaks
and holes (absolute height < 5 nm) (Figure 4.10 B). Extreme peaks and holes (>
100 nm) were less frequent. The lateral distribution of extreme surface features
was unique for each site. The total number of surface features on each site was
obtained by constructing a frequency distribution (representative graph shown in
Figure 4.10 C). Absolute numbers were variable between sites (data not shown);
however the frequency distribution demonstrated near-Gaussian properties for
every sample. In keeping with line analysis results, most data points were within
an absolute height value of 10nm from the mean feature height (~2nm). Note that
the distribution also indicates flat regions (height = 0).
The implication of these results must be discussed. Clearly, the nanoscale
topography of the recording sites produces an electroactive area that is much
greater than the geometric surface area. While this suggests improved sensitivity
measurements over a flat surface, it is important to note sensitivity also depends
on the probability that a surface will be reached by an electroactive molecule and
undergoes a chemical reaction. Accordingly, if a molecule cannot reach a narrow
cavity or a steep wall, these regions represent areas of less than average
reaction probability. Thus, total surface area does not necessarily translate to
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total accessible area. Such surface areas may also contribute to differences in
recording performance between Pt sites.
4.3.7 Machined Ceramic Faces are dominated by Nanometer–Sized
Microgrooves
A similar approach was used to map the front and reverse ceramic faces
of the microelectrode (Figure 4.11 A-C). The inner surfaces of the microgrooves
observed on the lower ceramic surface during SEM imaging were irregular in
shape but were relatively consistent in maximum depth (200 – 220 nm) for the
samples selected in this study. Roughness analysis (Table 4.3) generated RAVG
and RRMS values similar to the platinum sites. The most important finding in this
study was gained from the negative RSKEW and height distribution data which
indicated that holes were the dominating surface feature. (RSKEW = -2.2 and -0.4
respectively). Lastly, RAVG and RRMS values were extreme on the front surface
due to height variation between the ceramic base, the polyimide coating, the
connecting lines and the platinum sites. Together with the results from the
previous section, it is apparent that the topography and roughness characteristics
of the front and back faces of the MEA differ from each other and from the
ceramic sides.

4.4 Summary and Conclusion
When observed under the optical microscope, the machined surfaces of
our MEA appear smooth and light reflective. The studies conducted in this
chapter described these surfaces at sub-micron levels of spatial resolution using
scanning electron microscopy and atomic force microscopy. Recording sites on
the patterned face of the MEA appear recessed relative to adjacent surface due
to a coating of polyimide that covers the ceramic surface and connecting lines.
Polyimide also served to lower overall surface roughness. The opposite face of
the MEA consists of non-parallel microgrooves and focal pits that result in a
surface with low nanoscale roughness but high negative asymmetry. Also,
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microscale and nanoscale features were observed on the sides of the
microelectrode where the surface was dominated by irregular peaks and holes.
Thus each face of the MEA has a unique surface profile. The absence of oxygen
on the platinum surface was the most fascinating finding of this study along with
the discovery of platinum nanostructures that served to increase total recording
site area. Together, these results support that photolithographic fabrication
produces recording sites with naturally occurring nanoscale roughness and may
have a unique physical chemistry that warrants further investigation.
Copyright © Pooja Mahendra Talauliker 2010
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A

B

Figure 4.1: Comparison of slope and LODs of W4 and S2-MEAs. Figure A
shows that the average sensitivity (slope) of W4 MEAs (-5.7 x 10-3 nA∙µM-1 ± 6.8
x 10 -4, n = 14) and S2 MEAs (-7.5 x 10-3 nA∙µM-1 ± 1.3 x 10-4, n = 10) are not
significantly different while Figure B shows that the limit of detection was
significantly higher for W4 MEAs (0.61 µM ± 0.08, n = 14) when compared to S2
MEAs (0.24 µM ± 0.04, n = 10). **: (p < 0.0.1).
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Figure 4.2: Secondary electron micrographs of front surface of the MEA. A
and B are electron micrographs of the front surface of the MEA Except for the
working sites, the entire surface is enclosed underneath a continuous layer of
insulating polyimide. Panels C and D are high magnification images of the bare
Pt sites and show sub-micron sized irregularities in the form of peaks (blue
boxes) and indentations (red boxes).
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Figure 4.3: Secondary electron micrographs of the back surface and sides
of the MEA. Panels A and B show that the reverse face of the MEA is comprised
of intersecting microgrooves (width < 1 µm) and irregular holes (cross-sectional
area 0.1 – 10.0 µm2). In contrast, Panels C and D show that the sides of the
MEA are composed of an extensive network of interconnected pores that were
composed of clusters of smaller microfeatures (red contouring in D). Increased
brightness along the border of some structures in panel D is caused by edge
effects.
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Figure 4.4: Defects from photolithographic processing. Panels A and B show
delamination of the Pt/Ti composite from the recording sites and connecting
lines. Panels C and D show an offset in polyimide layer.
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Polyimide
Ceramic

Figure 4.5: Backscattered electron micrographs of MEA surfaces. Panel A is
a backscattered electron micrograph (BSE) of the front surface and sides of a
W4-MEA. The polyimide coating, ceramic substrate and Pt sites are
distinguishable based on their gray intensity levels. The polyimide layer appeared
to be homogenous because it showed uniform intensity. Panel B is a secondary
electron micrograph (SEI) of the same MEA shown for the sake of comparison.
The spatial resolution of an SEI image is greater than a BSE image.
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Figure 4.6: X-ray dispersive spectroscopy of Pt sites. Spectral analysis
confirmed that the recording sites are primarily composed of platinum. The
multiple platinum peaks on the graph are associated with excitation energy levels
of different electron orbitals. X-ray emissions corresponding to carbon and silver
were also detected. No other elements were detected.
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Figure 4.7: Atomic force microscopy of Pt sites. Topographical representation
of Pt recording surface: 15×15 µm (image A) and 1×1 µm regions (B). Variations
in surface height are shown in the form of a color gradient. Lighter shading is
indicative of regions with raised topography while darker areas correspond to
indentations or cavities.
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Figure 4.8: Three dimensional projections of Pt topography data. Graphs A
(15 µm2) and B (1 µm2) illustrate the shape and general distribution of peaks and
holes across sampled regions of the Pt site (perspective and profile views) on the
MEAs. Height scale and deflection range were adjusted for optimum viewing of
topographical information.
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20
Figure 4.9: Representative polyimide coated connecting line. Portion of a
polyimide coated Pt connecting line shown over a 20 x 20 µm region. Height
scale and deflection range were adjusted for optimum viewing of topographical
information. The connecting line is approximately 10 µm wide.
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Figure 4.10: Multiple line profiles and frequency distribution of surface
features on Pt sites. Panel A shows the line locations for multiple line scan
analysis on a 15x15 µm section of a Pt site. Panel B shows the corresponding
line profiles. Surface topography along each line was dominated by nanometer
sized peaks and holes (absolute height < 5 nm). Panel C is a frequency
distribution graph showing the total number of surface features on each Pt site.
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Figure 4.11: Frequency distribution of surface features on ceramic
substrate. Panel A is a three dimensional projection of the reverse MEA surface
over a 5x5 µm area. Panel B is a frequency distribution graph of surface heights
over this area and shows that negative heights were the dominant surface
feature.
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Table 4.1 Pt Site Sensitivity for Hydrogen Peroxide
Surface

Sensitivity

Type

Modification

Method

(pA∙µM-1∙mm-2)

Disk

Polished

Amperometry

1.4

Disk

Polished

Amperometry

6800

MEA

-

Amperometry

>9100

Planar

Pt nanowires

Amperometry

5.4
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Source
O’ Neill et
al., 2003
Guascito et
al., 2008
Burmeister
et al., 2002
Yang et al.,
2006

Table 4.2 Sample Roughness Analysis of Platinum Recording Sites
RAVG (nm)

RRMS (nm)

RSKEW

HMAX (nm)

|DMAX| (nm)

15 µm2

6.3

10.0

2.4

78.3

99.1

1 µm2

1.6

2.4

1.9

6.2

18.2

15 µm2

6.8

11.3

2.7

85.9

179.4

1 µm2

3.3

7.5

-4.7

61.3

12.3

15 µm2

17.9

30.0

3.8

219.0

368.6

1 µm2

1.6

2.2

1.6

5.2

7.6

Site 1

Site 2

Site 3

For each site, NSAMPLES per site = 3, NITERATIONS per sample = 3
15 µm2 Sampled Region: Height scale= 0 - 150 nm
1 µm2 Sampled Region: Height scale= 0 - 20 nm
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Table 4.3 Sample Roughness Analysis of Reverse Ceramic Surface
RAVG (nm)

RRMS (nm)

RSKEW

HMAX (nm)

|DMAX| (nm)

front

145.2

208.5

0

574.3

110.7

back

32.5

46.9

-1.8

132.6

213.4

front

125.8

180.0

-1.5

314.2

568.4

back

6.0

10.7

-1.13

97.4

-200.0

.
MEA 1

MEA 2

NITERATIONS per sample = 3
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Chapter Five: Investigations of Microprinting Technology as a Novel
Protein - Coating Tool for MEA Recording Surfaces

5.1 Introduction
We have developed ceramic based MEAs for acute and chronic
measurements of hippocampal single unit neuronal activity and neurotransmitter
regulation. The working sites of our MEAs are arranged in dorsal-ventral pairs at
the tip of the electrode. The built-in redundancy of this arrangement is useful for
verifying neurotransmitter changes in a given region or for identifying discrete
neuronal activity. However, for future dual recordings with multiple analytes, our
current manual enzyme-coating procedure must be modified to allow greater
control during enzyme application.
The present studies investigated the coating methodology and salient
characteristics of two computer-controlled microprinting devices, namely the
Nanoject microplotter and the Jetlab® microprinter. The former was customdesigned by our lab to allow micrometer precision for enzyme application
(Courtesy: Thomas Coates). The second system is a commercial microprinting
station (Microfab Technologies, Plano, TX) that can be adapted for enzyme
coatings. Choline oxidase and xanthine oxidase were selected for optimization
studies because they are relatively inexpensive compared to other oxidase
enzymes.

5.2 Materials and Methods
Please refer to Chapter Two for a detailed explanation about the principles
of piezoelectric-based inkjet printing utilized by the JetLab4® microprinting
station. Section 2.10 also includes details on cleaning procedures for jetting
device preparation and a brief overview of the JetLab4 software.
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5.3 Results and Discussion I: Nanoject Microplotter System for Application
of Enzyme Coatings on MEAs
The experiments described in this study have a considerably longer down
time (30 – 60 minutes) when compared to manual coatings (10 – 15 minutes).
Since gluteraldehyde is a strong cross-linking molecule, it was necessary to
prepare a solution of containing gluteraldehyde alone and a separate protein
solution of bovine serum albumin and enzyme. This prevented clogging of the
micropipette (or jetting device in section 5.4). In addition, the concentration of
BSA and protein concentration was 50% less than manual coatings (0.05% BSA
and 1 unit∙µL

-1

Choline Oxidase) while the gluteraldehyde concentration was

increased from 1.25% to 5%. The lower protein concentration aided in reduced
clogging of the tip while the higher gluteraldehyde concentration facilitated crosslinking on the Pt site.
5.3.1 Coating Methodology for W4-MEAs
The Nanoject Microplotter is a pressure-controlled continous jetting
system. Therefore, a pressure trigger causes the release of fluid from the
micropipette tip in the form of a continuous stream. Precise application of coating
solutions on each Pt site (Site width = 20 µm) of the MEA was achieved by using
micropipettes with a tip diameter of 20 – 30 µm and by positioning the tip directly
over (but not in contact with) the Pt site. Only one nozzle could be used at a time;
therefore, solutions of BSA/enzyme and gluteraldehyde were applied in tandem.
Clogging of the nozzle was prevented by using separate micropipettes for
gluteraldehyde and enzyme solutions or by flushing the micropipette with water
between solution applications.
We empirically determined that at least 8 serial applications of enzyme
solution and 4 applications of gluteraldehyde were needed to produce a stable
cross-linked enzyme layer. The performance of these MEAs was compared to
manual coatings. As seen in Figure 5.1, average slope and LOD values were not
significantly different between MEAs coated manually (1.4 x 10-2 nA∙µM ±
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1.4x10-3) and the with the nanoject microplotter (1.0 x 10--2 nA∙µM ± 1.6 x 10-3).
Thus, the nanoject microplotter allowed for discrete application of enzymes on Pt
sites while also maintaining the recording performance of these MEAs.
5.3.2 Challenges of Coating Procedure
Three main findings impacted the ease of using the Nanoject Microplotter
for routine enzyme coatings. First, the three dimensional motion of the
micropipette and the release of fluid was completely under human control. While
this allowed for greater coating precision, it also led to much longer coating times
(2-3 minutes per solution per MEA). Secondly, the present system utilizes a fixed
stage and moving printhead. This made it difficult to maintain the fluid stream in
continuous focus of the viewing microscope. Finally, a steady fluid flow was
observed only when relative humidity (RH) levels were > 60% at room
temperature. Though the entire unit was housed in a partially sealed Plexiglas®
chamber, approximately 4 hours were needed to raise the RH to desired levels.
Thus, during a single coating session, a turnover of 14 - 16 MEAs was achieved
with an active coating time of 60-90 minutes and a downtime of 30-40 minutes,
excluding time taken to reach desired RH levels. These challenges may be
addressed in part by automating the coating process and by fitting the
microscope with a viewing system such as a camera or computer monitor.

5.4 Results and Discussion II: Jetlab® Microprinting Station for Application
of Enzyme Coatings on MEAs
The Jetlab® microprinting station is a piezoelectric pulse-controlled jetting
system. Therefore, application of a brief potential causes release of fluid from the
tip of the jetting device in the form of droplets. The primary goal of this study was
to determine a range of operating conditions that allowed accurate printing of Pt
sites on W4-MEAs. This included optimization of droplet size, characterization of
drying behavior and evaluation of MEA performance. The latter was conducted at
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Microfab laboratories (Data courtesy Thom Coates and David Silva) and at the
University of Kentucky.
5.4.1 Calibration of Viewing Cameras and Translation Stages
The Jetlab4® hardware and software are provided with some basic
printing and testing capabilities such as a two-camera system that allows
visualization of ejected droplets (drop-observation camera) and printed substrate
(inspection camera) and user-defined calibration of stage motion. Water sensitive
paper (Ritterhouse Co., CA) was used as a print substrate for all calibrations.
The jetting device used in the present study is capable of generating droplets
with picoliter volumes (Cooley et al., 2001); therefore a 2X zoom lens was fitted
onto the inspection camera (downward-viewing) to allow droplet visualization on
the paper. Droplet evaporation and drift in droplet placement were minimized by
maintaining a height separation ≤ 2 mm between the jetting orifice and the MEA
tip (Figure 5.2). A screen-scale calibration was used to determine a scale
transformation from the coordinated motion of the stages in x- and y- directions
to the displacement calculated by the imaging software, as seen by the substrate
observation camera (Figure 5.3 A). This step was necessary to determine the
size of the impacted droplet, and for identifying the exact location of the MEA Pt
sites for printing. Next, a head-to-lens vector was calculated to determine the
distance to be moved in the x-y plane to place a spot from directly under the
jetting device to the center of view of the substrate observation camera (Figure
5.3 B). Finally, a test pattern was printed to correct for systematic deviations in
the placement of droplets over time (Figure 5.3 C).
5.4.2 Characterization of Pulse Parameters for Formation of Droplets
Formation of a droplet at the tip of the nozzle is controlled at the gross
level by a pneumatics box that allows control over positive and negative
pressure. For gluteraldehyde solution, we determined that a slight negative
pressure (-2 to -6 psi) was needed to release drops along a vertical trajectory. A
greater negative pressure (-4 to -12 psi) was needed to see similar behavior with
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choline oxidase and xanthine oxidase solutions. The back pressure also
minimized formation of satellite droplets. Fine control of droplet size and shape
was achieved by altering the characteristics of the pulse driving droplet ejection,
particularly the voltage and dwell times.
Figure 5.4 depicts the unipolar square waveform that was used for
gluteraldehyde solution. A separate waveform was generated for enzyme
solutions because of the propensity of these fluids to dry at the jetting tip. Figure
5.4 also shows a bipolar squarish waveform that combines features of square
and sine waves. This particular pulse caused low-level agitation of the meniscus
at the opening of the nozzle and minimized clogging. For each waveform, we
selected the lowest combination of voltage and dwell times to obtain the smallest
possible drop size. The Jetlab® software uses strobed illumination to estimate
the size, volume and planar deviation of droplets in mid-flight, allowing real-time
measurements of droplet characteristics. Voltage values between (±) 26 – 40 V
and dwell times between 10 – 25 µs produced stable droplets (diameter 60 – 85
µm) for both glutaredehyde and enzyme solutions.
5.4.3 Drying Behavior of Droplets on a Ceramic Substrate
For each solution, the drying behavior of droplets was evaluated. Droplet
characteristics were studied on a bare ceramic wafer to approximate drying
behavior on an MEA. The chemical and surface composition of the wafer was
identical to our MEAs. These experiments were conducted in a room maintained
at a constant temperature of 30°C and relative humidity of 30%. With each of the
three solutions, a few principal behaviors emerged when the distance between
adjacent drops was altered. Figure 5.5 shows photographs of these line
morphologies. Droplets spaced at distances greater than two times the droplet
radius dried as individual features. Decreasing the drop spacing to 1/4th of the
droplet radius allowed interaction between adjacent droplets. Partial merging was
observed though the original contact lines (droplet shape) were preserved,
resulting in the appearance of the ‘scalloped’ morphology. We noted that the
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width of the scalloped was less than isolated droplet width, likely due to
movement of the fluid along the axis of the line which decreased lateral
expansion (Soltman et al., 2008).
Further reduction of drop spacing eliminated the scalloped appearance
and produced a smooth, straight line. The width of these lines was the narrowest
of all observed line morphologies. Specifically, straight lines were obtained when
droplet spacing was between one-third and one-half of the radius. Finally, drops
that were printed closer than one-half of the radius demonstrated bulging along
discrete regions of the line. A recent study by Duineveld et al (2003) modeled
similar behavior in screen printed circuits. Their study proposed that droplets
tend to maintain their shape following substrate impaction because of surface
tension. However, when the amount of fluid exceeds the contact angle of the
droplets, surface tension cannot be maintained; therefore, droplets flow beyond
the initial contact angle, producing the bulge-like behavior observed in both
studies.
5.4.4 Automation of Coating Process
Using this data, we generated a custom script that printed arrays of
droplets with straight line morphologies. The script controlled stage motion and
droplet formation through the Jetlab® software (Sample script shown in Figure
A.1). MEAs were loaded on a custom Plexiglas® holder that aligned the tips in
the same x, y, z direction and minimized movement during printing. The holder
was fitted onto the stage provided for print jobs. The x-y coordinates of each site
were coded into the script. Activating the script resulted in automated printing of
individual coating solutions onto the MEAs. Separate jetting devices were
dedicated for each enzyme solution and the gluteraldehyde solution to reduce
the downtime of the coating process and to allow for selective coating of enzyme
onto discrete sites. Figure 5.6 (left) shows an MEA with choline oxidase enzyme
coated onto two discrete sites. Figure 5.6 (right) shows an MEA with xanthine
oxidase on left Pt sites and choline oxidase on the right Pt sites. Red dye
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(Rhodamine or Congo red) was mixed with coating solution to allow visualization
of the enzyme layer.
5.4.5 In Vitro Performance of Microprinted MEAs
Initial testing of MEA performance was conducted at Microfab laboratories
(data courtesy Thom Coates and David Silva). We empirically determined that at
a droplet size of 20 µm, at least 4 coats of enzyme solution (~400 nL) and 2
coats of gluteraldehyde solution (~200 nL) were required to produce a stable
enzyme layer. Together with the operating speed of the translation stages, the
current coating methodology is capable of coating up to 30 MEAs within 30
minutes. In vitro testing demonstrated that the microprinting procedure produced
enzyme coatings that were comparable to our manual coatings (Figure 5.7). At
the present time, we have not been able to replicate the necessary droplet size
or recording capability at the University of Kentucky. Light microscopy imaging
showed that large droplets peeled away from the Pt sites, possibly due to poor
cross-linking between gluteraldehyde and protein layers. Though future
experiments will focus on increasing the relative humidity around the jetting
orifice to reduce droplet size and increasing drying time, our preliminary
investigations have been successful.

5.5 Conclusion
The present studies have provided a wealth of characterization data for
two novel coating methodologies. Specifically, our studies on the Jetlab® system
suggest that this coating methodology offers a greater range of coating
capabilities, shorter coating time and greater control over solution properties.
Copyright © Pooja Mahendra Talauliker 2010
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Figure 5.1: Comparison of slope and LOD characteristics of manuallycoated and microplotter-coated MEAs. Statistical comparison of MEA
performance using students’ t-test found no significant differences between
manual coatings (n = 14) and nanoject microplotter (n = 9) coatings with respect
to average slope and LOD values.
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Figure 5.2: Vertical separation between jetting orifice and Pt Sites of MEA.
The jetting device used in the present study generates droplets with picoliter
volumes; therefore droplet evaporation and drift in droplet placement must be
minimized by maintaining a height separation ≤ 2 mm between the jetting orifice
and the MEA tip. Yellow circle enclose the jetting tip (filled with green dye) and
the MEA tip.
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Figure 5.3: Calibration of Jetlab® cameras and translation stages.
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Figure 5.3 (contd.) Panel A shows a droplet on water sensitive paper. Screenscale calibration of the camera can be used to determine the size of the droplet.
Panel B shows a pattern used for head-to-lens vector calibration. If calibration
was correctly performed, the center of the pattern will be positioned beneath the
jetting orifice. This was necessary for locating the precise position of MEA Pt
sites during printing. Panel C shows a pattern that is rotated by an angle of 20
degrees from its original position. Spot shift calibration was used to correct for
this error by superimposing identical patterns in the same location and measuring
the difference in the location of each spot. .
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Figure 5.4: Pulse waveforms used to control droplet size. Fine tuning of
droplet size and shape was achieved by altering the voltage and dwell times for
the piezoelectric pulse. A unipolar square waveform was used for gluteraldehyde
solution while a bipolar waveform that contained features of a square wave and a
sine wave was used for BSA/Enzyme Coatings.
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Figure 5.5: Common droplet behaviors observed during microprinting. The
behavior of protein and gluteraldehyde droplets following injection from the
microprinting nozzle was evaluated at a constant temperature of 30°C and
relative humidity of 30%. If droplets were printed at distances greater than two
times the droplet radius, they tended to be too far apart to interact with each
other. Decreasing the drop spacing to 1/4th of the droplet radius allowed droplet
interaction and merging though the original contact lines (droplet shape) were
preserved, resulting in the appearance of the ‘scalloped’ line. Straight lines were
obtained when droplet spacing was between 1/3 and 1/2 of the radius Drops that
were printed close than ½ the radius demonstrated bulging along discrete
regions of the line.
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Figure 5.6: Examples of high precision enzyme coatings using Jetlab
microprinting devices. The Jetlab® system allowed for precise application of
enzyme coatings on discrete MEAs. The MEA on the left has two sites coated
with choline oxidase and gluteraldehyde solutions. For the MEA on the right, Pt
sites on the left side are coated with choline oxidase while sites on the right side
are coated with xanthine oxidase. Red dye (Rhodamine or Congo red) was
mixed with coating solution to allow visualization of enzyme layers.
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Figure 5.7: Comparison of slope and LOD characteristics of manuallycoated and Jetlab®-coated MEAs. Statistical comparison of MEA performance
using students’ t-test found no significant differences between manual coatings
(n = 14) and Jetlab® microprinter coatings (n = 11) with respect to average slope
and LOD values.
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Chapter Six: Characterization of Tissue Responses to Chronic MEA
Implantation in the Hippocampus

6.1 Introduction
In vivo monitoring of extracellular glutamate is of interest to researchers
investigating synaptic mechanisms of hippocampal-dependent learning and
memory

formation

because

the

nerve

terminals

involved

in

synaptic

communication release glutamate molecules that in turn activate post-synaptic
glutamate receptors (Danbolt, 2001; Manabe, 2008). Outside of its role as an
excitatory neurotransmitter, glutamate is implicated in the pathophysiology of
diseases known to involve the hippocampus. An acute rise in basal glutamate
has been reported before and during a seizure event in the hippocampus of
patients with temporal lobe epilepsy (Cavus et al., 2005). In contrast, an overall
decrease in hippocampal glutamate has been shown for patients with
Alzheimer’s disease (for review see Greenamyre and Young, 1989). In both
cases, histopathological evidence for excitotoxic tissue damage has been
demonstrated (During and Spencer, 1993; Armstrong et al., 2003, respectively).
Therefore, there is also a need in the medical community to develop treatments
that control the adverse effects of glutamate dysregulation. Studies that combine
glutamate investigations with behavioral measurements offer the potential to
correlate neurochemical data with real time changes in hippocampal function.
Therefore, an investigative or diagnostic technique that allows chronic glutamate
measurements over multiple days is needed.
Microdialysis has been the historical gold standard for in vivo
neurochemical measurements though the slow sampling rate of this technique (5
– 20 minutes) is a significant limitation for measuring the rapid release and
clearance of glutamate in the brain (milliseconds – seconds) (Kennedy et al.,
2002; Watson, Venton and Kennedy, 2006). Chronic microdialysis experiments
usually last for only 6- 8 hours (Clapp-Lilly et al., 1999; Kennedy et al., 2002).
Further, the large-sized microdialysis probes (1 - 4 mm length, 0.2 - 0.3 diameter)
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produce considerable tissue damage (Clapp-Lilly et. al., 1999). Alternate
technologies with improved spatial and temporal resolution have been developed
using principles of electrochemistry. Of these, carbon fibers and hydrogel-based
electrodes have demonstrated success for measuring brain concentration of
catacholamines (Suaud-Chagny et al., 1993, Westerink, 2004) but not for
excitatory amino acid neurotransmitter recordings.
We have refined the salient features of both techniques and combined
them into a single versatile technology by developing ceramic-based MEAs for
chronic neurotransmitter measurements (Rutherford et al., 2007). The current
state of the technology allows for chronic glutamate measurements up to 7 days
in the prefrontal cortex (Rutherford et al., 2007) and up to 6 days in the
hippocampus (refer Chapter 3). Because the working sites of our MEAs are
composed of Pt, we also have the capability to record single unit neuronal activity
(Opris et al., 2009). In fact, chronic MEAs implanted into the rat hippocampus
have been shown to perform reliably for as long as six months (unpublished
data). Chapter 5 chronicled our efforts to modify our coating methodology to
allow improved adhesion of the enzyme layer to the Pt sites, particularly because
future experiments will involve long term chronic recordings with indwelling
MEAs. Parallel studies on the tissue responses to chronic MEA implantation
have conducted in the rat prefrontal cortex (PFC) (Hascup et al., 2009).
Immunohistochemical analysis of PFC tissues showed minimal tissue damage
and inflammation around MEA track up to six months. We believe that a separate
evaluation is needed for hippocampus implants because the unique anatomy and
physiology of this brain structure makes it vulnerable to damage from penetrating
electrodes. For example, Shorvon and Fish (2004) noted that insertion of depth
electrodes in the rat hippocampus was sometimes followed by a sudden rise in
activity of local neurons. Electroencephalographic data (EEG) from their study
was similar to electrical activity seen in transient epileptogenic foci (Meldrum and
Chapman, 2000). Similar observations have been reported by others, with a
greater likelihood of these occurring in the aging or diseased hippocampus
(Karhunen et al., 2005).
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It is important to note that astrocyte numbers in the hippocampus are
greater than most other brain regions (Savchenko et al., 2000) and are shown to
increase in an age-dependent manner (Takahashi et al., 2006). Astrocytes are
one of two major glial cell types participating in the inflammatory reaction to
tissue injury following electrode insertion (Biran et al., 2005, 2007). The other cell
type is microglia. These cells undergo morphological changes and accumulate
around the electrode in the days and weeks following implantation (Turner et al.,
1999, 2001). Furthermore, it is widely suggested that astrocytes and microglia
form a physical barrier that limits electrode access to healthy neurons (Polikov,
Reichert and Tresco, 2005). For glutamate investigations, glial changes in the
recording environment of the MEA present an additional challenge. Specifically,
glutamate transporters located on the cell membrane of astrocytes are the
primary mechanism by which glutamate is cleared from the extracellular
environment (Danbolt, 2001). The effect of astrocyte changes on glutamate
regulation is unknown.
The present study investigates tissues responses to chronic MEA
implantation in rat hippocampus. These experiments utilized non-recording MEAs
fitted with the complete recording pedestal and studied at time points 1, 3 and 7
days and 8, 16 and 24 weeks to evaluate the full biological response. Edema and
hemorrhaging immediately following surgery was studied by magnetic resonance
imaging (MRI) and cresyl violet staining. The latter was also used to verify
electrode placement and visualize the gross morphology of neuropil at each time
point. Changes in the morphology and distribution of hippocampal astrocytes and
microglia were determined using fluorescent antibody markers for glial fibrillary
acidic protein (GFAP) and microglial ionized calcium-binding adaptor molecule 1
(Iba1). Throughout this study, contralateral hippocampal tissue was used as a
control. GFAP was also used to determine astrocyte adhesion to the MEA
surface. Lastly, scanning electron microscopy (SEM) was used to study postsurgery changes in MEA topography.
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6.2 Materials and Methods
Chapter

Two

contains

a

comprehensive

description

about

the

experimental design and methodology followed in this study including fabricaton
and preparation of chronic MEAs, implant construction and in vivo assembly,
protocols on animal use, post-experimental tissue processing, microscopy
procedures, data selection and statistical analyses. For details about a specific
technique, please refer to relevant sections within this chapter.

6.3 Results
Animals exhibited normal behavior within 4 hours post-surgery and had
minimal post operative complications. At autopsy, we found that one animal had
improper MEA placement, one had extensive hemorrhaging, and two showed
signs of infection. These animals were removed from the study. We continue to
improve our surgery technique; however it is important to note that the present
experiments had a low complication rate.
6.3.1 Post-surgery Magnetic Resonance Imaging (MRI)
T1-weighted MRI of rat brain tissue were conducted immediately following
MEA implantation in the right hippocampus (Figure 6.1, A - L). A water-filled
capillary tube was used to mark the implanted hemisphere in these images.
Tissue was studied in serial coronal sections (500 µm thickness) to allow gross
visualization of the brain-MEA interface. Diminished contrast observed at the
insertion site suggested the presence of edema or hemorrhaging in the
extracellular environment surrounding the MEA (Figure 6.1 F - J). In addition, a
dark spot was noted near the track in sections C-E, possibly a microhemorrhage
in the sagittal plane that was caused during stereotactic insertion of the probe.
The temporal effects of these changes are described in the following sections
using conventional histology and immunohistochemistry.
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6.3.2 Cresyl Violet Staining
The distribution of cresyl violet in tissue sections was consistent with
accepted anatomical distributions of neuroglial cells in the rat hippocampus.
Moderate increases in staining (50 µm away from the track) were detected near
the implant track at day 1(Figure 6.2, A, C). Increased staining persisted up to 1
week (Figure 6.2 B, D) and was accompanied by small amounts of debris from
disruption of local vasculature. Moderate amounts of debris seen in the brain
parenchyma overlying the hippocampus was caused by bone screws that were
inserted too deep into the skull, evidenced by tissue disruption in both
hemispheres. The implant cavity was free of cellular matter. At 8 weeks postsurgery, distinct morphological changes were observed in tissue sections. A thin
layer of scar tissue lined portions of the insertion site, though this was not
apparent at low magnification (Figure 6.3 A, C). Very few samples contained
artifacts from hemorrhaging, suggesting that products of vascular disruption had
been cleared from the extracellular fluid by this time. The track produced by the
MEA was larger at 8 weeks (50 - 200 µm) and irregular in shape. Bands of tissue
and some scattered cells were observed inside the track and may have torn
away when the probe was removed. It was not possible to determine whether the
enlarged cavity was the result of in situ tissue damage or implant retrieval.
Similar changes were observed in hippocampal tissue sections 4 months after
surgery (Figure 6.3 B, D).
6.3.3 GFAP and Iba1 Immunoreactivity
In

the

present,

a

cell

with

stellate

morphology

and

positive

immunoreactivity to glial fibrillary acidic protein (GFAP, red) was assumed to be
an astrocyte. Similarly, cells showing positive immunoreactivity for ionized
calcium-binding adaptor molecule 1 (Iba1, green) were taken to be microglia.
Simultaneous detection of these cell types was achieved by exposing
hippocampal sections to both protein markers and studying the co-labeled tissue
by indirect immunofluorescence. Altered levels of GFAP near the insertion site
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were not readily apparent at days 1, 3 or 7 following implantation because of
overwhelming Iba1 immunoreactivity in this region. In addition, the pattern of
GFAP distribution in the hippocampus made it difficult to distinguish between
normal and reactive astrocytes at these time points (Figure 6.4 A – F). Very few
GFAP positive astrocytes were observed inside the track or along its perimeter.
Thus, we tentatively suggest that astrocytes may not be a major component of
the cellular sheath up to 7 days post-implantation.
Hippocampal

coronal

sections

obtained

8

weeks

post-surgery

demonstrated intense GFAP immunoreactivity around the implant track (Figure
6.5 A, C). The extended processes of reactive astrocytes contributing to the glial
scar were readily distinguishable from normal astrocytes.

These processes

formed long tangled bundles that radiated away from the track perimeter,
extending up to 100 µm into surrounding tissue. Interestingly, cell bodies could
not be visualized within the glial sheath, though the tangled morphology of the
processes suggested a multilayered composition. Similar to the cresyl violet data,
the track was wider at later time points. The track interior also contained isolated
filamentous particles that were GFAP immunoreactive. These particles may be
astrocyte processes that broke off during implant retrieval. At 4 months (16
weeks) post-surgery, the width of the glial sheath decreased and became more
compact (Figure 6.5 B- D). Gliotic tissue was still multilayered though a decrease
in the total number of cells was observed. Interestingly, cell bodies were now
distinguishable from each other and there was a marked decrease in the length
of astrocytic processes. As before, the inner surface of the cellular sheath was
disrupted, evidenced by irregular lumen shape and ribbons of dislodged gliotic
tissue extending across the track. This type of partial tissue disruption in long
term implants suggests that adhesion between cells in the sheath was
comparable to cell adhesion at the MEA surface.
Quantitative estimation of total GFAP immunoreactivity at all data points
showed that increased staining intensity was detected at day 1 following MEA
implantation (Figure 6.6). A significant increase in intensity levels was measured
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at 1 week (p<0.001). Beyond 8 weeks a decrease in GFAP levels was noted
though overall immunoreactivity remained significantly elevated (p<0.05) for the
duration of the implant.
Figure 6.4 (A - F) also shows representative images of Iba1
immunoreactivity (green) in the hippocampus at days 1, 3 and 7 following MEA
insertion. At distances greater than 50 µm from the track, low levels of Iba1 were
detected throughout the hippocampus. Based upon their stellate morphology,
most cells appeared to be non-reactive. Reactive microglia with amoeboid
morphology were observed close to the implant cavity and were surrounded by
an amorphous fluid-like substance that also showed low-level immunoreactivity.
At days 3 and 7, microglia formed a diffuse multilayered network. The absence of
a defined implant cavity suggested that the microglial sheath collapsed when the
MEA was removed, indicating poor intercellular adhesion. Increased microglial
content in the overlying cortical layers were correlated with tissue damage noted
in cresyl violet sections. Iba1 immunoreactivity subsided dramatically by 8 weeks
and was not easily differentiated from control tissue at later time points (Figure
6.5 A – D). Furthermore, images obtained at high magnification showed that very
few cells exhibited amoeboid morphology.
Since Iba1 is a generalized marker for microglia, the proportion of reactive
and unreactive cells at various time points could not be determined. Despite this,
gray level measurements revealed interesting quantitative data about total Iba1
content in implanted tissue. Gray intensity measurements obtained 1 day after
microelectrode implantation were slightly decreased when compared to control
tissue. These levels became significant at 1 week (p < 0.05). Total intensity
levels remained significantly high until 8 weeks, though wide variance was
observed in the data at this time point (Figure 6.6). Diminished gray levels were
seen at 4 and 6 months.
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6.3.4 Surface Characterization of Explanted MEAs
Following implant removal from perfusion-fixed tissue, tissue adhesion on
MEA surfaces was investigated using SEM. Samples were viewed in a high
vacuum environment; therefore, some distortion of cellular architecture was
expected. All MEA showed evidence of attached biological material. However,
the distribution of tissue was variable between samples. For the MEAs examined
in this study, there was no correlation between implant time and tissue content.
Other than the probe shown in Figure 6.7 B, only one other MEA was covered
with thick layers of closely associated cell matter. In both samples, the
microstructure of the probe was not visible and individual cells or cell processes
could not be distinguished. All other samples were similar to probe A where the
recording surface had very little tissue and only a few scattered cells (Figure 6.7
C). Adhering material was usually found on the sides or along edges in isolated
clusters. High magnification images showed that some of these clusters were
composed of cellular debris in multiple layers that were held together by a
smooth amorphous material (Figure 6.7 C, D). We also observed cell-free
regions covered solely by the amorphous layer (Figure 6.7 E). Both types of
tissue could be found on a single probe. For example, the MEA in Figure 6.7 A
has a coating on the vertical side near the base that starts out as an amorphous
layer that transitions into a thin cell-like layer and fuses with a thick tissue cluster
on the horizontal surface.
Finally, a subset of freshly removed MEAs was retained for tissue fixation
and immunohistochemistry analysis. Except for a discrete region on one probe
(Figure 6.8 A), all samples were negative for GFAP indicating an absence of
astrocytes on MEA surfaces. High magnification imaging of the GFAP positive
region showed fragment resembling astrocytic processes, but no whole cells
(Figure 6.8 C). The amorphous coating detected during SEM was also observed
during confocal imaging in the form of a thin layer that covered most of the MEA
(Figure 6.8 B, D). The identity of this material could not be determined. Additional
immunological markers were not tested because the SEM and GFAP studies
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collectively suggest that attachment of non-astrocytic cells on the MEA surface
was unlikely. These results also support that the large void left behind in tissue
sections is not to due to removal of tissue during implant retrieval.

6.4 Discussion
These studies demonstrate that our chronic MEAs were well-tolerated in
the hippocampus up to six months post-surgery. MEA insertion into the brain
produced edema, hemorrhaging and rapid alterations in local microglia and
astrocytes. At all time points, the MEA was surrounded by a highly active cellular
sheath that was immunoreactive for GFAP (astrocytes) and Iba1 (microglia).
Temporal changes in the morphology and spatial distribution of cells inside the
sheath and in surrounding tissue were studied by immunohistochemical staining,
which also allowed quantification of fluorescent intensities and comparison with
control tissue samples. Briefly, Iba1 levels were significantly elevated from 1 to 8
weeks post-surgery but were diminished at later time points. GFAP
immunoreactivity was also significant by 1 week remained high even 6 months
after surgery. Interestingly, the cellular sheath produced in response to MEA
insertion was less than 100 µm wide suggesting that only tissue in the immediate
vicinity was affected. After 4 months, the sheath contracted and became more
compact, further reducing the extent of the biological response (≤ 50 µm). These
results indicate that minimal tissue damage resulted from insertion of the probe
and its prolonged presence in the hippocampus. Only two explanted probes (out
of 30) showed limited GFAP immunoreactivity confirming a lack of astrocytic
content on the ceramic surface. In addition, SEM studies showed that very little
tissue adhered to the ceramic surface indicative of weak cell attachment to the
implant. As discussed below, these findings have important implications for future
electrochemical and electrophysiological investigations involving chronic MEAs.
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6.4.1 MEAs are Well-Tolerated in the Rat Hippocampus
The present studies demonstrated that our MEAs were well-tolerated up to
six months in the hippocampus, a brain region known for high susceptibility to
trauma-induced neurodegeneration (Shorvon and Fish, 2004). The low
complication rate observed in these experiments is an important result because it
emphasizes the significance of quality surgical procedures. Brain implantation of
any penetrating electrode is a difficult process; despite this, current scientific
research on the impact of initial insertion conditions is limited (Turner et al., 1999;
Parlikar and Clement, 2008). For our experiments, we used a stereotactic frame
coupled to a high-precision microdrive so that the MEA was inserted vertical to
the brain surface at a slow and steady rate of 0.1 mm∙s-1. The tapered MEA
design, rigidity of the ceramic material may have contributed to reducing tissue
damage (Polikov, Tresco and Reichert, 2003). We also removed dura overlying
the brain surface, which minimizes dimpling of the brain surface during insertion
(Szarowski et al., 2003). Lastly, non-steroidal inflammatory drugs were
administered to minimize pre-operative stress and alleviate post-operative
inflammation at the surgery site. Animal recovery was also aided by providing a
soft food diet and saline injections (for dehydration) as needed.
6.4.2 Hippocampal Tissue Response to Chronic MEAs Demonstrates
Overlapping Acute and Chronic Phases
Microglia appear to accumulate around the MEA track as early as day 1
post -implantation, verified by the increased Iba1 staining seen in this region.
Interestingly, this was not reflected by mean intensity levels, which were lower
than control values. A possible explanation is the migration of existing microglial
cells to the track from surrounding tissue rather than production of new cells
(Szarowski et al., 2003). The loss of processes during activation of stellateshaped

unreactive

microglia

to

amoeboid,

reactive

microglia

to

this

transformation may also account for the apparent decrease in Iba1 staining (for
review, see Polikov, Tresco and Reichert, 2003).
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Iba1 levels were significantly higher than control between 1 and 8 weeks
(p<0.001 and p<0.05), but diminished at later time points. Similar changes in
microglial distribution have been reported in response to electrode insertion
though not at the same time points (Stensaas and Stensaas, 1976; Turner et al.,
1999b; Szarowski et al., 2003; Biran et al., 2005). Since hemorrhaging debris
was absent beyond 8 weeks in cresyl violet stained sections and Iba1
immunoreactivity was diffuse at 4 and 6 months, it appears that microglia are
activated in response to insertion related damage and remain in place until
products from disrupted tissue and vasculature are removed from the
extracellular matrix. At the same time, Iba1 intensity did not return to control
levels. This low level, persistent response has been attributed to the continued
presence of the electrode in the brain (Yuen and Agnew, 1995; Rousche et al.,
2001; Csicsvari et al., 2003; Biran et al., 2005). These results support the
prevailing view that the microglia response to injury is characterized by distinct
acute and chronic phases (for review, see Polikov, Reichert and Tresco, 2003).
Knowledge about the time course and spatial extent of the microglial
reaction is important because activated microglia are known to secrete both
neuroprotective and neurotoxic substances (Elkabes et al., 1996; Nakajima et al.,
2001; Giulian et al., 1993a, b) which may either prevent extension of dendrites to
the MEA or induce neuronal death. Microglia also produce chemicals that recruit
additional microglial to the injury site and upregulate the proliferation of this cell
type (Elkabes et al., 1996). Because of these extracellular effects, microglia can
act as a chemical barrier to electrode-neuron communication if their range of
diffusion overlaps with the recording zone of our MEAs (Tresco et al., 2000).
Finally, activated microglia can serve as an indirect physical barrier because they
promote the formation of a glial scar that encapsulates the injury site (Tresco et
al., 2000).
In the present experiments, average GFAP levels were elevated in
implanted hippocampal tissue within 1 day. These levels continued to rise and
became significant at one week though aggregation of GFAP positive cells or
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reactive astrocyte morphology was not discernible around the implant cavity.
Mean density levels remained significantly high at 8 weeks but maximum GFAP
intensity was concentrated near the track. Increased staining was clearly due to a
well-developed sheath of reactive astrocytes, which extended

100 µm into

surrounding tissue and must have formed several weeks earlier. Diminished
intensity levels beyond 4 months is probably associated with contraction of both
astrocyte processes and the sheath itself, which now only extended to 50 µm
away from the cavity.
Similar to microglial cells, the rapid upregulation of reactive astrocytes and
their subsequent accumulation in the cellular sheath within a few weeks presents
several challenges to recording longevity. Neuron growth and repair is an
extremely slow process; therefore it takes several days for neurons to form
proper connections with the recording sites. Because of this, even a thin, welldeveloped gliotic scar is an effective physical and electrical insulator that shields
the electrode from the rest of the brain (Nathaniel and Nathaniel, 1981; Landis,
1994). With respect to glutamate measurements, the glial scar presents an
additional impediment because increased astrocyte density can alter glutamate
clearance mechanisms. The glutamate transport capacity of reactive astrocytes
is unknown. Accordingly, future neurochemical studies will need to be extended
for longer times. It is also important to investigate alterations in the distribution of
neurons and their processes around the chronic MEA over time.
6.4.3 Tissue Responses to Chronic MEAs is Different in the PFC and
Hippocampus
We have previously investigated the brain tissue reaction to MEAs
implanted in the PFC of Long Evans rats (Hascup et al., 2009). In the PFC, the
cellular sheath surrounding the implant track was contained within 50-100 µm of
the inner track surface at all time points. A similar result was observed with
hippocampal implants in the present study supporting that the volume of tissue
responding to the MEA is similar in both regions (Figure 6.9). With respect to
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control tissue, PFC levels of GFAP were increased 4 fold (Control: 3.77 ± 0.77; 1
Week = 16.15 ± 6.6) whereas hippocampal GFAP levels were increased 2 – 3
fold (Control: 13.49 ± 1.0, 1 week = 33.82 ± 6.5). However, comparison of GFAP
intensities at common time points showed that total astrocyte levels were
approximately two fold higher in the hippocampus (GFAPHippocampus / GFAPPFC :
Day 3 = 2.18; Day 7 = 2.09; Month 6 = 1.86). These results suggest that relative
change from control was greater in the PFC but absolute numbers were higher in
the hippocampus. The most straightforward explanation for this discrepancy is
that the hippocampus contains more astrocytes than the PFC (Danbolt, 2001).
Further, the studies were carried out in different rat strains and may account for
differences in total astrocytes numbers (Gosselin et al., 2008), though actual data
from previous research is limited. It is possible that increased astrocyte numbers
lead to an enhanced repair response in the hippocampus. Alternately, the cellular
and molecular composition of the two regions may be different, possibly affecting
wound response and repair.
Differences in experimental design can also lead to different results. The
PFC study used MEAs coated with Nafion® while the present study used bare
MEAs. Ceramic alumina is inherently hydrophilic, has high porosity and high
wettability (Coors Manual S1785), all of which limit astrocyte adhesion (Biran et
al., 2005). This is supported by the present SEM and immunohistochemical data.
Our ceramic MEAs also have low nanoscale roughness (Chapter Four). Unlike
ceramic, Nafion® has dual hydrophilic-hydrophobic properties and studies on the
biocompatibility of Nafion and other polysulphonated polymers are contradictory.
Leung et al (2008) showed that Nafion coatings increase adhesion of microglia to
hydrophobic surfaces. In contrast, Turner and colleagues (1990, 1991)
demonstrated a minimal tissue response to intraperitoneal and intravenous
nafion

membrane

implants.

Clearly,

additional

studies

on

the

brain

biocompatibility of Nafion are needed.
Finally, the MEA used in the present studies were implanted along with
the complete chronic assembly to approximate the actual weight of probes used
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in recording experiments. The PFC implants only consisted of a microelectrode
tip held in place by dental cement (Hascup et al., 2009). The added weight may
contribute to increased internal pressure around the implant, potentially causing
greater damage in vivo (for review, see Polikov, Reichert and Tresco, 2003).
Comparison of Iba1 levels showed that control microglial levels are similar in
both regions. In the hippocampus staining levels were moderately higher than
PFC at the same time points, but these data were not significant.
6.4.4 Chronic MEAs Produce Minimal Tissue Damage in the Rat
Hippocampus
The study by Hascup et al also evaluated the tissue effects of chronically
implanted microdialysis probes. Microdialysis has traditionally been the gold
standard for in vivo neurochemistry measurement; therefore a direct comparison
of long term tissue effects is important to understand performance differences
between this technique and our microelectrode technology. Approximately 1
week after implantation, non-dialysized probes produced tissue reactions
extending

to

300

µm

in

the

rat

prefrontal

cortex

investigated

by

Immunohistochemical staining. Other studies based on electron microscopy,
voltammetry and fluorescent staining have described a range of distances for
acute tissue injury, extending from 300 µm to 1.4 mm (Clap-Lilly et al., 1999;
Borland et al., 2005; Mitala et al., 2008; Jaquins-Gerstl and Michael, 2009).
Together with the results of the present study, we can state with confidence that
our MEA technology causes minimal tissue damage relative to chronic
microdialysis probes.
Based on a review of scientific literature, neuronal recording devices such
as silicon shank electrodes and platinum or titanium wire electrodes appear to
produce greater insertion injury than our MEAs (Turner et al., 1999; Szarowski et
al., 2003). It is important to note that these devices are geometrically narrower
than our ceramic MEAs (6-12 µm), yet they produced cellular sheaths extending
500-600 µm into external tissue. Though factors such as probe shape (Nicolelis
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et al., 2003), texture (Rousche et al., 2001) and insertion conditions (Szarowski
et al., 2003) are expected to impact implant biocompatibility, recent studies have
shown that these factors do not affect the chronic tissue response (12 weeks
after implantation) (Szarowski et al., 2003). These data can lead to the
assumption that the acute response is not as important as the long term effects.
However, theoretical modeling and direct measurements support that the
maximum distance between an electrode and a neuron soma must be of the
order of cell dimensions to maintain recording performance (Mountcastle, 1957;
Rall, 1962; Rosenthal, 1972; Henze et al., 2000). This distance is directly
dependent upon the initial tissue reaction because it affects neuronal survival
near the probe (Shain et al., 2002). Thus, for indwelling devices like our MEAs, it
is important to also evaluate biocompatibility from a functional perspective, i.e.,
long term recording capability.
The most important finding in support of this hypothesis comes from
chronic electrophysiological recordings using our MEAs. We have successfully
recorded single unit neuronal activity in the unanesthetized rat hippocampus up
to six months (unpublished data by S. Deadwyler and R. Hampson). In this
study, hippocampal single-unit neuronal recordings were conducted in rats in
conjunction with behavioral measurements, also known as place field
measurements (Figure 6.10). Briefly, the Pt sites measured electrical activity of
individual pyramidal neurons (place cells) in the hippocampus while the animal
explored its environment. Since each neuron has a unique electrical signature,
the identity of the neuron can determined by correlating individual firing rates with
a range of spatial locations (place fields) in the animal’s environment (principal
component analysis). Using this technique, neuronal processing of hippocampal
dependent learning and memory events can be investigated. One month
following implantation, discrete neuronal activity was measured on all Pt sites,
and place fields were generated within thirty minutes of placing an animal in a
novel environment (Figure 6.10). Similar single unit recordings and place maps
could be generated six months later from the same animals. At this time point,
the electrical signature measured by the sites was altered (Figure 5.10),
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suggesting a change in the extracellular environment around the MEA either due
to internal movement or due to a change in the properties of the neurons that
were recorded. Together, these results unequivocally support the minimal
damage caused by our MEAs.
Copyright © Pooja Mahendra Talauliker 2010
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Figure 6.1: T1-weighted magnetic resonance imaging of the brain-MEA
interface. Images are shown in serial coronal sections (500 µm thickness). A
water-filled capillary tube is used to mark the implanted hemisphere (white arrow
in image A). Note the diminished contrast at the insertion site indicative of edema
or hemorrhaging around the MEA (yellow arrow in Image H). A dark spot noted
near the track in sections C-E (black arrow in image C) may be a
microhemorrhage in the sagittal plane.
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Figure 6.2: Cresyl violet imaging of the MEA track at days 1 and 7. Panels A
and C correspond to low and high magnification images of 1 day implants.
Panels B and D correspond to low and high magnification images of 1 week
implants. Brown staining in tissue sections is debris from hemorrhaging. Arrows
indicate well-defined tracks at all time points. Scale A, B: 300 µm, Scale C, D:
150 µm.
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Figure 6.3: Cresyl violet imaging of microelectrode track at weeks 8 and 16.
Panels A and C correspond to low and high magnification images of 8 week
implants. Panels B and D correspond to low and high magnification images of 16
week implants. Arrows indicate tracks that are wider at these time points.
Increased staining is not seen around the track. Scale A, B: 300 µm, Scale C, D:
150 µm.
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Figure 6.4: Tissue sections colabeled for GFAP and Iba1 at days 1, 3 and 7
after chronic MEA implantation. GFAP (red) and Iba1 (green) labeled tissue
shown at day 1 (A, D), day 3 (B. E) and day 7(C, F) after surgery. Iba 1 staining
is markedly elevated around the implant track. Scale A-C: 100 µm, Scale D-F: 40
µm. White arrows indicate track location.
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Figure 6.5: Tissue sections colabeled for GFAP and Iba1 at weeks 8 and 16
after chronic MEA implantation. GFAP (red) and Iba1 (green) labeled tissue
shown at 8 weeks (A, C) and 16 weeks (B. D) after surgery. A well-defined glial
scar is seen at 8 weeks. It becomes contracted and more compact by 4 months.
Scale A-C: 100 µm, Scale D-F: 40 µm. White arrows indicate track location.
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Figure 6.6: Quantitative analysis of mean GFAP and Iba1 immunoreactivity
around MEA tracks in the rat hippocampus. Gray levels of GFAP (Panel A)
and Iba1 (Panel B) immunoreactivity around the MEA track were compared for
time points ranging from 1 day to 6 months following implantation in the rat
hippocampus, relative to control tissue. Statistical comparisons were conducted
using a One way ANOVA followed by Dunnet’s Test. GFAP immunoreactivity
was significantly higher by 1 week (33.8 ± 6.8) and remained elevated up to 6
months. Iba1 levels were also significantly elevated by 1 week (32.9 ± 3.2) but
diminished after 8 weeks. Significance was defined as *: p<0.05, **: p<0.01, ***:
p<0.001

142

Figure 6.7: Scanning electron micrographs of biological material on MEA
samples. The MEAs shown in panels A and B were removed 3 weeks after
implantation in the rat hippocampus. Most MEA samples were similar in
appearance to Panel A and had very little tissue on the ceramic and Pt surfaces.
Only one other MEA resembled panel B and was fully covered with biological
material. Panels C and D are high magnification electron micrographs showing
tissue debris on the side of the MEA. Panel shows an amorphous cell-free layer
that was also found on several MEA samples.
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100 µm

50 µm

Figure 6.8: GFAP staining of tissue material on MEAs. Panels A and C
correspond to low and high magnification images for a microelectrode that
showed positive immunoreactivity to GFAP. Panels B and D correspond to a low
and high magnification images of typical microelectrode following implantation.
GFAP immunoreactivity was not observed. Scale bar: A, C = 100 µm; C, D = 50
µm.
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Figure 6.9: Comparison of mean GFAP and Iba1 immunoreactivity around
MEA tracks in the PFC of Long Evans rats and hippocampus of F344 rats.
Gray levels of GFAP (Panel A) and Iba1 (Panel B) immunoreactivity around the
MEA track were compared for time points ranging from 1 day to 6 months
following implantation in the hippocampus of F344 rats (black), and in the PFC of
Long Evans rats (white) (data courtesy Erin Hascup), relative to respective
control tissue samples. Statistical comparisons were conducted using a two way
ANOVA followed by Bonferroni’s post hoc test. Significance was defined as. *:
p<0.05.
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Figure 6.10: Chronic recordings of multiple single-neuron activity in the rat
hippocampus using MEAs.
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Figure 6.10 (contd.) Place field measurements were obtained in conjunction with
hippocampal single unit neuronal recordings from chronically implanted rats. One
month following implantation, discrete neuronal activity could be measured on all
working sites, and place fields were generated within thirty minutes of placing an
animal in a novel environment. Similar single unit recordings and place maps
could be generated six months later from the same animals though the electrical
signature measured by the sites was different from 1 month recordings. (Data
courtesy Sam Deadwyler and Rob Hampson)
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Conclusions
The studies described in this dissertation showed that the micrometer
targeting capability of the novel W4-MEA in conjunction with rapid amperometric
recordings is a powerful tool for investigations of in vivo glutamate regulation.
Potassium stimulation of nerve terminals in discrete hippocampal subregions
revealed that release and uptake of evoked glutamate is a fast process (5-10
seconds). Particularly in the DG and CA3, glutamate release appears to be under
tight presynaptic control. Dissimilarities in regulation of glutamate observed in
these studies have potentially provided direct evidence for distinct subregional
roles in hippoampal processing of cognitive information. Though the trisynaptic
circuit is widely suggested to be the primary pathway for information relay
throughout the hippocampus, neuroscientists have shown that each subregion of
the hippocampus is unique with respect to cellular distribution, subcellular
content and synaptic connectivity. I believe that future work combining
pharmacological investigations with glutamate recordings can elucidate the effect
of these differences on the mechanism hippocampal function.
Our anesthetized studies did not include investigations of glutamate
regulation during a disease process but are extremely relevant to understanding
changes

in

hippocampal

function

in

neurodegenerative

conditions

like

Alzheimer’s disease. The entorhinal cortex (EC) is the first brain structures to be
affected in Alzheimer’s disease (AD). Since perforant path projections from the
EC to the DG are the primary excitatory input to the hippocampus, loss of EC
axons is expected to affect the terminal end of these projections. However, the
CA1 is the first hippocampal substructure to show neurodegenerative changes.
Until now, a satisfactory explanation for the progressive loss of excitatory
pyramidal neurons has not been available though an indirect excitatory
component has been suggested. This hypothesis has received some support in
the scientific community because partial blockade of NMDA receptors with lowaffinity antagonists like Memantine have been shown to improve cognitive
function in Alzheimer’s disease. At the same time, we do not know whether
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receptor dysregulation is due to changes in afferent inputs from the triysaptic or
parallel excitatory projections from the EC through the alvear pathway, perhaps
both. Future experiments involving selection deactivation or lesioning of
individual pathways followed by real-time glutamate recordings have the potential
to provide novel insight about the pathology of AD.
While acute studies can provide a wealth of data about hippocampal
glutamatergic circuitry, we recognize that combined studies of glutamate and
behavior offer the greatest potential for understanding the functional role of this
excitatory neurotransmission. The experiments conducted in this dissertation
support our current capability to measure resting glutamate from the CA1
subregion of unanesthetized rats for up to six days. Since resting glutamate was
stable over multiple days, a second goal of this dissertation was characterization
and optimization of our chronic MEA technology for extended hippocampal
recordings in awake, behaving animals as long as six months.
Scanning electron microscopy and atomic force microscopy of Pt sites
showed that the ceramic surface of the MEA has an inherent nanoscale
roughness. Prior research has shown that this type of surface supports neuronal
growth but does not permit astrocyte attachment (Polikov, Tresco and Reichert,
2003). We were able to verify the latter through immunohistochemical studies
while collaborative investigations (with Dr. Ingrid Stromberg at the University of
Umeá) to study neuronal distribution at the brain-MEA interface are already
underway. We also initiated studies to improve our enzyme coating procedure.
Presently, enzyme coatings on our MEAs are applied by hand. This method
offers limited control over the coating thickness and uniformity both within and
between MEAs. The Jetlab® microprinter (Microfab Technologies, Plano, TX)
offers the capability to apply picoliter volumes of coating solutions onto discrete
Pt sites. With respect to in vitro performance, our preliminary results have been
extremely promising. We also achieved dual enzyme coatings that allowed for
detection of two analytes by the MEA simultaneously. In summary, the studies
presented in this dissertation have made several inroads towards our goal of
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conducting long-term neurotransmitter investigations. Some questions have been
answered, at the same time, we are now presented with several exciting
opportunities for future investigations.
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Appendix: Custom Script for Jetlab Printing Trials

Figure A.1: General script that can be customized for jetlab-based enzyme
coatings. The Jetlab® system is controlled by its namesake, the Jetlab®
software. During a printing trial, the software can recall a custom-coded script
that controls droplet formation from the jetting device while simultaneously
directing the motion of the translation stages. The script shown above can be
modified for a variety of MEA designs and coating solutions. It can also be used
to control the motion of multiple jetting devices.
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